Neutrophils	B-cell_type
and	O
monocytes	B-cell_type
express	O
high	O
levels	O
of	O
PU.1	B-protein
(	O
Spi-1	B-protein
)	O
but	O
not	O
Spi-B	B-protein
.	O

PU.1	B-protein
(	O
the	O
Spi-1	B-DNA
oncogene	I-DNA
)	O
and	O
Spi-B	B-protein
are	O
closely	O
related	O
members	O
of	O
the	O
ets	B-protein
transcription	I-protein
factor	I-protein
family	I-protein
,	O
sharing	O
similar	O
DNA	O
binding	O
specificities	O
mediated	O
by	O
similar	O
DNA	B-protein
binding	I-protein
domains	I-protein
.	O

PU.1	B-protein
and	O
Spi-B	B-protein
have	O
been	O
previously	O
described	O
as	O
being	O
predominantly	O
expressed	O
coordinately	O
in	O
macrophages	B-cell_type
and	O
B	B-cell_type
cells	I-cell_type
,	O
but	O
their	O
expression	O
in	O
early	O
hematopoietic	O
stages	O
and	O
during	O
the	O
course	O
of	O
myeloid	O
differentiation	O
to	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
or	O
to	O
neutrophils	B-cell_type
has	O
not	O
been	O
extensively	O
investigated	O
.	O

Here	O
,	O
we	O
report	O
that	O
PU.1	B-RNA
mRNA	I-RNA
is	O
upregulated	O
during	O
myeloid	O
differentiation	O
of	O
human	B-cell_line
purified	I-cell_line
CD34+	I-cell_line
cells	I-cell_line
and	O
murine	B-cell_line
multipotential	I-cell_line
FDCP-mix	I-cell_line
A4	I-cell_line
cells	I-cell_line
,	O
suggesting	O
that	O
PU.1	B-protein
is	O
upregulated	O
as	O
an	O
early	O
event	O
during	O
differentiation	O
of	O
multipotential	B-cell_type
progenitor	I-cell_type
cells	I-cell_type
.	O

PU.1	B-protein
expression	O
is	O
maintained	O
at	O
stable	O
levels	O
during	O
differentiation	O
of	O
myeloid	B-cell_line
cell	I-cell_line
lines	I-cell_line
U937	B-cell_line
and	O
HL-60	B-cell_line
to	O
monocytic	B-cell_type
and	I-cell_type
neutrophilic	I-cell_type
cells	I-cell_type
.	O

PU.1	B-protein
is	O
expressed	O
at	O
highest	O
levels	O
in	O
mature	B-cell_type
human	I-cell_type
monocytes	I-cell_type
and	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
neutrophils	I-cell_type
.	O

In	O
contrast	O
to	O
PU.1	B-protein
,	O
significant	O
levels	O
of	O
Spi-B	B-RNA
mRNA	I-RNA
and	O
protein	O
are	O
found	O
only	O
in	O
some	O
B-cell	B-cell_line
lines	I-cell_line
and	O
spleen	O
but	O
are	O
not	O
found	O
in	O
myeloid	B-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
neutrophils	B-cell_type
,	O
or	O
macrophages	B-cell_type
.	O

In	O
vitro	O
translated	O
Spi-B	B-protein
protein	I-protein
can	O
bind	O
to	O
PU.1	B-DNA
binding	I-DNA
sites	I-DNA
in	O
myeloid	B-DNA
promoters	I-DNA
and	O
transactivate	O
these	O
promoters	B-DNA
in	O
nonmyeloid	B-cell_type
cells	I-cell_type
.	O

Therefore	O
,	O
although	O
PU.1	B-protein
and	O
Spi-B	B-protein
may	O
bind	O
to	O
similar	O
DNA	O
control	O
elements	O
and	O
have	O
redundancy	O
of	O
transactivation	O
function	O
in	O
vitro	O
,	O
the	O
lack	O
of	O
significant	O
levels	O
of	O
Spi-B	B-protein
in	O
myeloid	B-cell_type
cells	I-cell_type
makes	O
it	O
unlikely	O
that	O
Spi-B	B-protein
plays	O
a	O
significant	O
role	O
in	O
myeloid	O
lineage	O
development	O
and	O
gene	O
expression	O
.	O

In	O
contrast	O
,	O
PU.1	B-protein
is	O
expressed	O
at	O
high	O
levels	O
not	O
only	O
in	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
but	O
also	O
in	O
neutrophils	B-cell_type
,	O
indicating	O
that	O
PU.1	B-protein
can	O
activate	O
gene	O
expression	O
in	O
both	O
major	B-cell_type
myeloid	I-cell_type
lineages	I-cell_type
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Neutrophils	NULL
and	NULL
Monocytes	NULL
Express	NULL
High	NULL
Levels	NULL
of	NULL
PU.1	NULL
(	NULL
Spi-1	NULL
)	NULL
But	NULL
Not	NULL
Spi-B	NULL
By	NULL
Hui-min	NULL
Chen	NULL
,	NULL
Pu	NULL
Zhang	NULL
,	NULL
Maria	NULL
Teresa	NULL
Voso	NULL
,	NULL
Stefan	NULL
Hohaus	NULL
,	NULL
David	NULL
A.	NULL
Gonzalez	NULL
,	NULL
Christopher	NULL
K.	NULL
Glass	NULL
,	NULL
Dong-Er	NULL
Zhang	NULL
,	NULL
and	NULL
Daniel	NULL
G.	NULL
Tenen	NULL
PU.1	NULL
(	NULL
the	NULL
Spi-1	NULL
oncogene	NULL
}	NULL
and	NULL
Spi-B	NULL
are	NULL
closely	NULL
related	NULL
members	NULL
of	NULL
the	NULL
ets	NULL
transcription	NULL
factor	NULL
family	NULL
,	NULL
sharing	NULL
similar	NULL
DNA	NULL
binding	NULL
specificities	NULL
mediated	NULL
by	NULL
similar	NULL
DNA	NULL
binding	NULL
domains	NULL
.	NULL

PU.1	NULL
and	NULL
Spi-B	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
as	NULL
being	NULL
predominantly	NULL
expressed	NULL
coordinately	NULL
in	NULL
macrophages	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
their	NULL
expression	NULL
in	NULL
early	NULL
hematopoietic	NULL
stages	NULL
and	NULL
during	NULL
the	NULL
course	NULL
of	NULL
myeloid	NULL
differentiation	NULL
to	NULL
monocytes	NULL
and	NULL
macrophages	NULL
or	NULL
to	NULL
neutrophils	NULL
has	NULL
not	NULL
been	NULL
extensively	NULL
investigated	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
report	NULL
that	NULL
PU.1	NULL
mRNA	NULL
is	NULL
upregulated	NULL
during	NULL
myeloid	NULL
differentiation	NULL
of	NULL
human	NULL
purified	NULL
CD34*	NULL
cells	NULL
and	NULL
murine	NULL
multipotential	NULL
FDCP-mix	NULL
A4	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
PU.1	NULL
is	NULL
upregulated	NULL
as	NULL
an	NULL
early	NULL
event	NULL
during	NULL
differentiation	NULL
of	NULL
multipotential	NULL
progenitor	NULL
cells	NULL
.	NULL

PU.1	NULL
expression	NULL
is	NULL
maintained	NULL
at	NULL
stable	NULL
levels	NULL
during	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cell	NULL
lines	NULL
U937	NULL
and	NULL
HL-60	NULL
to	NULL
monocytic	NULL
and	NULL
neutrophilic	NULL
cells	NULL
.	NULL

PU.1	NULL
is	NULL
expressed	NULL
at	NULL
highest	NULL
levels	NULL
in	NULL
mature	NULL
human	NULL
monocytes	NULL
and	NULL
human	NULL
peripheral	NULL
HE	NULL
RELATED	NULL
TRANSCRIPTION	NULL
factors	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
playing	NULL
important	NULL
roles	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL
'	NULL

''	NULL
PU.1	NULL
is	NULL
the	NULL
product	NULL
of	NULL
the	NULL
Spi-1	NULL
oncogene	NULL
whose	NULL
expression	NULL
is	NULL
activated	NULL
by	NULL
the	NULL
acute	NULL
leukemo-genic	NULL
retrovirus	NULL
spleen	NULL
focus-forming	NULL
virus	NULL
in	NULL
murine	NULL
erythro-leukemia	NULL
.	NULL
'	NULL

''	NULL
Overexpression	NULL
of	NULL
PU.1	NULL
in	NULL
developing	NULL
erythro-blasts	NULL
results	NULL
in	NULL
a	NULL
block	NULL
of	NULL
erythroid	NULL
differentiation	NULL
.	NULL

``	NULL
°	NULL
Spi-B	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
B-cell	NULL
library	NULL
using	NULL
the	NULL
conserved	NULL
3	NULL
'	NULL
region	NULL
of	NULL
the	NULL
PU.1	NULL
cDNA	NULL
as	NULL
a	NULL
probe	NULL
.	NULL
``	NULL

These	NULL
two	NULL
genes	NULL
share	NULL
similar	NULL
DNA	NULL
binding	NULL
domains	NULL
and	NULL
binding	NULL
specificities	NULL
.	NULL
``	NULL

PU.1	NULL
and	NULL
Spi-B	NULL
belong	NULL
to	NULL
the	NULL
Ets	NULL
family	NULL
and	NULL
share	NULL
a	NULL
DNA	NULL
binding	NULL
motif	NULL
that	NULL
recognizes	NULL
a	NULL
purine-rich	NULL
sequence	NULL
along	NULL
with	NULL
the	NULL
other	NULL
members	NULL
of	NULL
this	NULL
family	NULL
,	NULL
including	NULL
Ets-1	NULL
,	NULL
Ets-2	NULL
,	NULL
Elk-1	NULL
,	NULL
Erg	NULL
,	NULL
Elf-1	NULL
,	NULL
and	NULL
PEA3	NULL
.	NULL

``	NULL
°	NULL
PU.1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
promoters	NULL
of	NULL
multiple	NULL
macrophage	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
(	NULL
M-CSFR	NULL
)	NULL
,	NULL
the	NULL
macrophage	NULL
scavenger	NULL
receptor	NULL
,	NULL
and	NULL
CD11b	NULL
,	NULL
and	NULL
is	NULL
critical	NULL
for	NULL
their	NULL
macrophage-specific	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
In	NULL
B	NULL
cells	NULL
,	NULL
PU.1	NULL
also	NULL
regulates	NULL
the	NULL
J-chain	NULL
promoter	NULL
and	NULL
the	NULL
Ig	NULL
\2-4	NULL
and	NULL
«	NULL
3'-enhancers	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
PU.1	NULL
is	NULL
a	NULL
cell	NULL
type-specific	NULL
activator	NULL
and	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
macrophages	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
``	NULL
implying	NULL
that	NULL
it	NULL
may	NULL
From	NULL
the	NULL
Hematology/Oncology	NULL
Division	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
;	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Medicine	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
.	NULL

Submitted	NULL
September	NULL
3	NULL
,	NULL
1994	NULL
;	NULL
accepted	NULL
January	NULL
1	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
No	NULL
.	NULL

CA41456	NULL
and	NULL
DK48660	NULL
(	NULL
to	NULL
D.G.T	NULL
.	NULL
)	NULL

and	NULL
CA59589	NULL
(	NULL
to	NULL
D-E.Z	NULL
)	NULL
.	NULL

H.-m.C	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
Fellowship	NULL
from	NULL
The	NULL
Medical	NULL
Founda-tion	NULL
.	NULL

D.G.T	NULL
.	NULL

is	NULL
a	NULL
Scholar	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

S.H	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Mildred-Scheel-Stiftung	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Daniel	NULL
G.	NULL
Tenen	NULL
,	NULL
MD	NULL
,	NULL
Research	NULL
East	NULL
219	NULL
,	NULL
Beth	NULL
Israel	NULL
Hospital	NULL
,	NULL
330	NULL
Brookline	NULL
Ave	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02215	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
2918	NULL
blood	NULL
neutrophils	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
PU.1	NULL
,	NULL
significant	NULL
levels	NULL
of	NULL
Spi-B	NULL
mRNA	NULL
and	NULL
protein	NULL
are	NULL
found	NULL
only	NULL
in	NULL
some	NULL
B-cell	NULL
lines	NULL
and	NULL
spleen	NULL
but	NULL
are	NULL
not	NULL
found	NULL
in	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
neutrophils	NULL
,	NULL
or	NULL
macrophages	NULL
.	NULL

In	NULL
vitro	NULL
translated	NULL
Spi-B	NULL
protein	NULL
can	NULL
bind	NULL
to	NULL
PU.1	NULL
binding	NULL
sites	NULL
in	NULL
myeloid	NULL
promoters	NULL
and	NULL
transactivate	NULL
these	NULL
promoters	NULL
in	NULL
nonmyeloid	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
although	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
may	NULL
bind	NULL
to	NULL
similar	NULL
DNA	NULL
control	NULL
elements	NULL
and	NULL
have	NULL
redundancy	NULL
of	NULL
transactivation	NULL
function	NULL
in	NULL
vitro	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
significant	NULL
levels	NULL
of	NULL
Spi-B	NULL
in	NULL
myeloid	NULL
cells	NULL
makes	NULL
it	NULL
unlikely	NULL
that	NULL
Spi-B	NULL
plays	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
myeloid	NULL
lineage	NULL
development	NULL
and	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PU.1	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
not	NULL
only	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
but	NULL
also	NULL
in	NULL
neutrophils	NULL
,	NULL
indicating	NULL
that	NULL
PU.1	NULL
can	NULL
activate	NULL
gene	NULL
expression	NULL
in	NULL
both	NULL
major	NULL
myeloid	NULL
lineages	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
their	NULL
differentiation	NULL
and/or	NULL
activation	NULL
.	NULL

Previous	NULL
studies	NULL
indicated	NULL
that	NULL
PU.1	NULL
was	NULL
expressed	NULL
in	NULL
early	NULL
granulocytic	NULL
,	NULL
erythroid	NULL
,	NULL
and	NULL
megakaryocytic	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
in	NULL
mature	NULL
erythroid	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
and	NULL
was	NULL
downregulated	NULL
in	NULL
the	NULL
course	NULL
of	NULL
differentiation	NULL
of	NULL
erythroid	NULL
cell	NULL
lines	NULL
.	NULL

Our	NULL
own	NULL
studies	NULL
in	NULL
human	NULL
CD34*	NULL
cells	NULL
indicated	NULL
that	NULL
PU.1	NULL
was	NULL
upregulated	NULL
during	NULL
myeloid	NULL
(	NULL
granulocyte-macrophage	NULL
CSF	NULL
[	NULL
GM-CSFj-induced	NULL
)	NULL
differentiation	NULL
but	NULL
not	NULL
during	NULL
erythroid	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
.	NULL
``	NULL

In	NULL
contrast	NULL
to	NULL
its	NULL
high	NULL
levels	NULL
of	NULL
expression	NULL
in	NULL
macrophages	NULL
,	NULL
PU.1	NULL
protein	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
mature	NULL
murine	NULL
neutrophils	NULL
,	NULL
suggesting	NULL
that	NULL
its	NULL
expression	NULL
was	NULL
upregulated	NULL
during	NULL
monocytic	NULL
and	NULL
possibly	NULL
downregulated	NULL
during	NULL
neutrophilic	NULL
differentiation	NULL
of	NULL
myeloid	NULL
progenitors	NULL
.	NULL
'	NULL

''	NULL
The	NULL
pattern	NULL
of	NULL
PU.1	NULL
expression	NULL
in	NULL
mature	NULL
monocytic	NULL
cells	NULL
,	NULL
combined	NULL
with	NULL
the	NULL
role	NULL
of	NULL
PU.1	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
myeloid-specific	NULL
integrin	NULL
CD11b	NULL
and	NULL
the	NULL
M-CSFR	NULL
(	NULL
a	NULL
key	NULL
growth	NULL
factor	NULL
receptor	NULL
for	NULL
the	NULL
macrophage	NULL
lineage	NULL
)	NULL
,	NULL
suggested	NULL
that	NULL
PU.1	NULL
might	NULL
have	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
stem	NULL
cells	NULL
to	NULL
the	NULL
macrophage	NULL
lineage	NULL
,	NULL
just	NULL
as	NULL
GATA-1	NULL
is	NULL
essential	NULL
for	NULL
erythroid-lineage	NULL
development	NULL
.	NULL
``	NULL

''	NULL
Recent	NULL
studies	NULL
using	NULL
competitor	NULL
oligonucleotides	NULL
to	NULL
block	NULL
PU.1	NULL
function	NULL
showed	NULL
its	NULL
critical	NULL
role	NULL
in	NULL
myeloid	NULL
and	NULL
colony	NULL
formation	NULL
.	NULL

*	NULL
Studies	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
Spi-B	NULL
have	NULL
been	NULL
more	NULL
limited	NULL
but	NULL
have	NULL
suggested	NULL
that	NULL
its	NULL
expression	NULL
might	NULL
be	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
PU.1	NULL
.	NULL
'	NULL

To	NULL
study	NULL
the	NULL
possible	NULL
role	NULL
of	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
in	NULL
commitment	NULL
and	NULL
differentiation	NULL
of	NULL
bone	NULL
marrow	NULL
(	NULL
BM	NULL
)	NULL
stem	NULL
cells	NULL
to	NULL
the	NULL
myeloid	NULL
lineage	NULL
and	NULL
,	NULL
eventually	NULL
,	NULL
to	NULL
mature	NULL
cells	NULL
,	NULL
we	NULL
analyzed	NULL
their	NULL
expression	NULL
(	NULL
1	NULL
)	NULL
during	NULL
myeloid	NULL
commitment	NULL
of	NULL
multipotential	NULL
CD34	NULL
*	NULL
cells	NULL
and	NULL
in	NULL
murine	NULL
FDCP	NULL
cells	NULL
,	NULL
(	NULL
2	NULL
)	NULL
during	NULL
myeloid	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
(	NULL
3	NULL
)	NULL
in	NULL
primary	NULL
human	NULL
myeloid	NULL
cells	NULL
and	NULL
murine	NULL
tissues	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
Spi-B	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
at	NULL
significant	NULL
levels	NULL
only	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
PU.1	NULL
is	NULL
upregulated	NULL
during	NULL
myeloid	NULL
differentiation	NULL
of	NULL
multipotential	NULL
human	NULL
and	NULL
murine	NULL
cells	NULL
and	NULL
is	NULL
expressed	NULL
at	NULL
highest	NULL
levels	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
most	NULL
prominently	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
are	NULL
likely	NULL
to	NULL
play	NULL
very	NULL
distinct	NULL
roles	NULL
in	NULL
hematopoiesis	NULL
and	NULL
that	NULL
PU.1	NULL
,	NULL
not	NULL
Spi-B	NULL
,	NULL
is	NULL
likely	NULL
to	NULL
regulate	NULL
neutrophil	NULL
as	NULL
well	NULL
as	NULL
macrophage	NULL
gene	NULL
expression	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
85	NULL
,	NULL
Na	NULL
10	NULL
(	NULL
May	NULL
15	NULL
)	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
2918-2928	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PU.1	NULL
AND	NULL
Spi-B	NULL
EXPRESSION	NULL
IN	NULL
MYELOID	NULL
CELLS	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Preparation	NULL
,	NULL
enrichment	NULL
,	NULL
and	NULL
culture	NULL
of	NULL
CD34*	NULL
progenitor	NULL
cells	NULL
.	NULL

Human	NULL
BM	NULL
mononuclear	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
discarded	NULL
filter	NULL
sets	NULL
from	NULL
normal	NULL
donors	NULL
or	NULL
from	NULL
patients	NULL
with	NULL
solid	NULL
tumors	NULL
without	NULL
BM	NULL
involvement	NULL
,	NULL
undergoing	NULL
BM	NULL
harvest	NULL
for	NULL
transplantation	NULL
.	NULL

CD34*	NULL
progenitors	NULL
were	NULL
enriched	NULL
by	NULL
an	NULL
immunomagnetic	NULL
selection	NULL
technique	NULL
,	NULL
``	NULL
``	NULL
modified	NULL
as	NULL
follows	NULL
.	NULL

BM	NULL
mononuclear	NULL
cells	NULL
,	NULL
obtained	NULL
by	NULL
a	NULL
Ficoll	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
density	NULL
gradient	NULL
were	NULL
depleted	NULL
of	NULL
the	NULL
adherent	NULL
fraction	NULL
,	NULL
followed	NULL
by	NULL
fractionation	NULL
on	NULL
a	NULL
3-step	NULL
Percoll	NULL
(	NULL
Pharmacia	NULL
)	NULL
gradient	NULL
(	NULL
densities	NULL
:	NULL
1,054	NULL
,	NULL
1,066	NULL
,	NULL
and	NULL
1,077	NULL
g/mL	NULL
)	NULL
.	NULL

Cells	NULL
with	NULL
the	NULL
lowest	NULL
density	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
CD34	NULL
antibody	NULL
(	NULL
IMMU133	NULL
;	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Immunotech	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
)	NULL
and	NULL
,	NULL
subsequently	NULL
,	NULL
with	NULL
goat	NULL
antimouse	NULL
IgG1-coated	NULL
immunomagnetic	NULL
beads	NULL
(	NULL
Dynabeads	NULL
;	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

The	NULL
CD34*	NULL
population	NULL
was	NULL
then	NULL
isolated	NULL
on	NULL
a	NULL
magnetic	NULL
particle	NULL
concentrator	NULL
.	NULL

CD34-enriched	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
a	NULL
liquid	NULL
medium	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10,000/mL	NULL
in	NULL
RPMI	NULL
1640	NULL
,	NULL
supplemented	NULL
with	NULL
2	NULL
mmol/L	NULL
glutamine	NULL
,	NULL
100	NULL
pg/mL	NULL
penicillin-streptomycin	NULL
,	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
55°C	NULL
for	NULL
30	NULL
minutes	NULL
;	NULL
Hyclone	NULL
,	NULL
Logan	NULL
,	NULL
Utah	NULL
)	NULL
,	NULL
human	NULL
recombinant	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
;	NULL
0.01	NULL
U/mL	NULL
)	NULL
,	NULL
and	NULL
human	NULL
GM-CSF	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
daily	NULL
.	NULL

To	NULL
obtain	NULL
a	NULL
CD34*/CD38~	NULL
population	NULL
,	NULL
the	NULL
low-density	NULL
cells	NULL
from	NULL
the	NULL
Percoll	NULL
gradient	NULL
fractionation	NULL
described	NULL
above	NULL
were	NULL
subjected	NULL
to	NULL
cell-sorting	NULL
on	NULL
a	NULL
Coulter	NULL
EPICS	NULL
750	NULL
Flow	NULL
Cytometer	NULL
(	NULL
Coulter	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
first	NULL
separated	NULL
with	NULL
anti-CD34-fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
antibody	NULL
(	NULL
HPCA-2	NULL
;	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
CD34	NULL
*	NULL
population	NULL
was	NULL
then	NULL
further	NULL
separated	NULL
into	NULL
CD34	NULL
*/	NULL
CD38~	NULL
and	NULL
CD34*/CD38*	NULL
populations	NULL
using	NULL
a	NULL
CD38-phycoer-ythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
antibody	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

The	NULL
CD34*/	NULL
CD38~	NULL
population	NULL
represented	NULL
2	NULL
%	NULL
of	NULL
the	NULL
starting	NULL
population	NULL
of	NULL
nonadherent	NULL
Ficoll-and	NULL
Percoll-purified	NULL
cells	NULL
.	NULL

Revese	NULL
transcription-polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
analysis	NULL
of	NULL
CD34*	NULL
cell	NULL
cultures	NULL
.	NULL

-	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
up	NULL
to	NULL
100,000	NULL
cells	NULL
according	NULL
to	NULL
the	NULL
single-step	NULL
isolation	NULL
method	NULL
``	NULL
``	NULL
using	NULL
Tri-Reagent	NULL
(	NULL
Molecular	NULL
Research	NULL
Center	NULL
,	NULL
Inc	NULL
,	NULL
Cincinnati	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

First-strand	NULL
cDNA	NULL
was	NULL
synthesized	NULL
by	NULL
RT	NULL
(	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
RT	NULL
)	NULL
using	NULL
random	NULL
hexamers	NULL
as	NULL
primer	NULL
(	NULL
GIBCO-BRL	NULL
,	NULL
Gaith-ersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Each	NULL
cycle	NULL
of	NULL
PCR	NULL
included	NULL
1	NULL
minute	NULL
of	NULL
denaturation	NULL
at	NULL
95°C	NULL
,	NULL
1	NULL
minute	NULL
of	NULL
primer	NULL
annealing	NULL
3°C	NULL
below	NULL
the	NULL
melting	NULL
temperature	NULL
(	NULL
Tm	NULL
)	NULL
required	NULL
by	NULL
the	NULL
set	NULL
of	NULL
oligonucleotides	NULL
used	NULL
,	NULL
and	NULL
90	NULL
seconds	NULL
of	NULL
extension/synthesis	NULL
at	NULL
72°C	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
the	NULL
PCR	NULL
primer	NULL
set	NULL
for	NULL
human	NULL
were	NULL
5'-TGGAAGGGTTTC-CCCTCGTC-3	NULL
'	NULL
(	NULL
bp	NULL
201	NULL
to	NULL
220	NULL
of	NULL
the	NULL
cDNA	NULL
)	NULL
and	NULL
5'-TGCTGTCCTTGATGTCGCCG-3	NULL
'	NULL
(	NULL
bp	NULL
746	NULL
to	NULL
727	NULL
)	NULL
;	NULL
for	NULL
CD11b	NULL
,	NULL
they	NULL
were	NULL
(	NULL
bp	NULL
2304	NULL
to	NULL
2320	NULL
of	NULL
the	NULL
CDI11Ib	NULL
cDNA	NULL
)	NULL
and	NULL
5'-TCCAAGGGAAGCCTTGC-3	NULL
'	NULL
(	NULL
bp	NULL
2755	NULL
to	NULL
2739	NULL
)	NULL
;	NULL
for	NULL
human	NULL
Spi-B	NULL
,	NULL
they	NULL
were	NULL
5'-ACCATGCTCGCC-CTGGA-3	NULL
'	NULL
(	NULL
bp	NULL
4	NULL
to	NULL
20	NULL
of	NULL
the	NULL
cDNA	NULL
``	NULL
)	NULL
and	NULL
5'-GGC-TAGCGAAGTTCTCC-3	NULL
'	NULL
(	NULL
bp	NULL
342	NULL
to	NULL
326	NULL
)	NULL
;	NULL
and	NULL
for	NULL
GAPDH	NULL
,	NULL
the	NULL
primer	NULL
set	NULL
was	NULL
(	NULL
bp	NULL
388	NULL
to	NULL
405	NULL
of	NULL
the	NULL
GAPDH	NULL
cDNA	NULL
)	NULL
and	NULL
5-CAAGTTGTCATGGATGACC-3	NULL
'	NULL
(	NULL
bp	NULL
582	NULL
to	NULL
563	NULL
)	NULL
.	NULL

A	NULL
negative	NULL
control	NULL
reaction	NULL
,	NULL
containing	NULL
water	NULL
instead	NULL
of	NULL
cDNA	NULL
,	NULL
was	NULL
included	NULL
in	NULL
each	NULL
PCR	NULL
amplification	NULL
to	NULL
exclude	NULL
the	NULL
presence	NULL
of	NULL
possible	NULL
DNA	NULL
contamination	NULL
.	NULL

cDNA	NULL
from	NULL
different	NULL
time	NULL
points	NULL
was	NULL
amplified	NULL
using	NULL
PCR	NULL
conditions	NULL
in	NULL
the	NULL
exponential	NULL
range	NULL
of	NULL
amplification	NULL
.	NULL

The	NULL
PCR	NULL
amplification	NULL
is	NULL
linear	NULL
so	NULL
long	NULL
as	NULL
the	NULL
reaction	NULL
is	NULL
performed	NULL
in	NULL
the	NULL
exponential	NULL
range	NULL
of	NULL
amplification	NULL
,	NULL
at	NULL
a	NULL
constant	NULL
efficiency	NULL
.	NULL

For	NULL
these	NULL
reasons	NULL
,	NULL
we	NULL
performed	NULL
kinetic	NULL
studies	NULL
of	NULL
RT-PCR	NULL
amplification	NULL
for	NULL
the	NULL
different	NULL
genes	NULL
studied	NULL
(	NULL
PU.1	NULL
,	NULL
CD1	NULL
1b	NULL
,	NULL
and	NULL
GAPDH	NULL
)	NULL
,	NULL
using	NULL
an	NULL
equivalently	NULL
low	NULL
input	NULL
of	NULL
RNA	NULL
(	NULL
12	NULL
ng	NULL
)	NULL
from	NULL
human	NULL
myeloid	NULL
lines	NULL
that	NULL
we	NULL
estimated	NULL
we	NULL
had	NULL
harvested	NULL
from	NULL
CD34	NULL
*	NULL
cell	NULL
cultures	NULL
.	NULL

The	NULL
same	NULL
amount	NULL
of	NULL
RNA	NULL
was	NULL
reverse-transcribed	NULL
and	NULL
amplified	NULL
with	NULL
specific	NULL
primer	NULL
sets	NULL
for	NULL
different	NULL
genes	NULL
,	NULL
and	NULL
one	NULL
eighth	NULL
of	NULL
the	NULL
reaction	NULL
was	NULL
harvested	NULL
every	NULL
5	NULL
cycles	NULL
.	NULL

Once	NULL
a	NULL
linear	NULL
range	NULL
was	NULL
established	NULL
for	NULL
each	NULL
set	NULL
of	NULL
2919	NULL
primers	NULL
,	NULL
increasing	NULL
amounts	NULL
of	NULL
RNA	NULL
(	NULL
from	NULL
50	NULL
pg	NULL
to	NULL
100	NULL
ng	NULL
)	NULL
were	NULL
amplified	NULL
in	NULL
a	NULL
linear	NULL
fashion	NULL
.	NULL

Quantitation	NULL
of	NULL
RNA	NULL
extracted	NULL
from	NULL
an	NULL
estimated	NULL
equal	NULL
number	NULL
of	NULL
CD34*	NULL
cells	NULL
and	NULL
their	NULL
progeny	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
GAPDH-band	NULL
intensity	NULL
.	NULL

The	NULL
cDNA	NULL
resulting	NULL
from	NULL
the	NULL
same	NULL
RT	NULL
was	NULL
then	NULL
diluted	NULL
according	NULL
to	NULL
the	NULL
GAPDH	NULL
signal	NULL
intensity	NULL
and	NULL
amplified	NULL
as	NULL
described	NULL
above	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
separated	NULL
in	NULL
a	NULL
1.5	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
positive-charged	NULL
nylon	NULL
membrane	NULL
(	NULL
Biotrans	NULL
;	NULL
ICN	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

PU.1	NULL
and	NULL
GAPDH	NULL
messages	NULL
were	NULL
hybridized	NULL
to	NULL
the	NULL
corresponding	NULL
cDNA	NULL
labeled	NULL
with	NULL
a-	NULL
``	NULL
P-deoxycytidine	NULL
triphosphate	NULL
by	NULL
the	NULL
hexanucleotide	NULL
random	NULL
priming	NULL
method	NULL
.	NULL
``	NULL

Internal	NULL
oligonucleotides	NULL
,	NULL
labeled	NULL
as	NULL
described	NULL
,	NULL
``	NULL
were	NULL
used	NULL
for	NULL
CD11b	NULL
hy-bridization	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
induction	NULL
of	NULL
differentiation	NULL
.	NULL

-	NULL
Human	NULL
promono-cytic	NULL
U937	NULL
cells	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
[	NULL
ATCC	NULL
]	NULL
no	NULL
.	NULL

CRL	NULL
1593	NULL
;	NULL
ATCC	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
human	NULL
promyelocytic	NULL
HL-60	NULL
cells	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

CCL	NULL
240	NULL
)	NULL
,	NULL
T-lymphoblastic	NULL
Jurkat	NULL
cells	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

TIB	NULL
152	NULL
)	NULL
,	NULL
CML	NULL
cell	NULL
line	NULL
K-562	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

243	NULL
)	NULL
,	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
RAJI	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

CCL86	NULL
)	NULL
,	NULL
B-lymphoblastic	NULL
BJA-B	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
murine	NULL
monocyte-macrophage	NULL
cell	NULL
line	NULL
RAW	NULL
264.7	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

TIB	NULL
71	NULL
)	NULL
,	NULL
and	NULL
murine	NULL
B-lymphoma	NULL
cell	NULL
line	NULL
A20	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

TIB	NULL
208	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
(	NULL
GIBCO-BRL	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Hyclone	NULL
)	NULL
and	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
.	NULL

Human	NULL
cervical	NULL
carcinoma	NULL
HeLa	NULL
cells	NULL
{	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

CCL	NULL
2	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
media	NULL
(	NULL
BRL	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
newborn	NULL
calf	NULL
serum	NULL
and	NULL
2	NULL
mmol/L	NULL
L-glutamine	NULL
.	NULL

The	NULL
murine	NULL
myeloma	NULL
line	NULL
$	NULL
p2/0-Ag14	NULL
(	NULL
ATCC	NULL
no	NULL
.	NULL

CRL	NULL
1581	NULL
)	NULL
was	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
4.5	NULL
g/L	NULL
glucose	NULL
and	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Human	NULL
monocytic	NULL
cell	NULL
line	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
murine	NULL
pro-B-lymphocyte	NULL
cell	NULL
line	NULL
LyD9	NULL
were	NULL
maintained	NULL
as	NULL
described	NULL
.	NULL
``	NULL

FDCP-mix	NULL
A4	NULL
is	NULL
a	NULL
multipotential	NULL
IL-3~dependent	NULL
cell	NULL
line	NULL
derived	NULL
from	NULL
murine	NULL
long-term	NULL
BM	NULL
culture	NULL
and	NULL
maintained	NULL
in	NULL
Fisher	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
WEHI-3B-conditioned	NULL
medium	NULL
as	NULL
a	NULL
source	NULL
of	NULL
IL-3	NULL
and	NULL
with	NULL
20	NULL
%	NULL
horse	NULL
serum	NULL
.	NULL
``	NULL

U937	NULL
and	NULL
HL-60	NULL
cells	NULL
were	NULL
induced	NULL
for	NULL
6	NULL
days	NULL
with	NULL
10	NULL
°	NULL
mol/L	NULL
retinoid	NULL
acid	NULL
or	NULL
with	NULL
3	NULL
x	NULL
10~°	NULL
mol/L	NULL
12-0-tetradecanoylphorbol-13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
.	NULL

FDCP-mix	NULL
A4	NULL
cells	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
in	NULL
Iscove	NULL
's	NULL
Medium	NULL
(	NULL
BRL	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
0.1	NULL
%	NULL
WEHI-3B-conditioned	NULL
medium	NULL
,	NULL
and	NULL
2.5	NULL
ng/mL	NULL
murine	NULL
GM-CSF	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Glaxo	NULL
,	NULL
Geneva	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

RNA	NULL
preparations	NULL
and	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
guanidium	NULL
isothiocyanate	NULL
extraction	NULL
followed	NULL
by	NULL
cesium	NULL
chloride	NULL
gradient	NULL
purification	NULL
.	NULL
``	NULL

RNA	NULL
(	NULL
10	NULL
pg/lane	NULL
)	NULL
was	NULL
denatured	NULL
in	NULL
formamide/formaldehyde	NULL
followed	NULL
by	NULL
electrophoresis	NULL
in	NULL
1	NULL
%	NULL
agarose/formaldehyde	NULL
gels	NULL
.	NULL

RNA	NULL
was	NULL
then	NULL
transferred	NULL
to	NULL
Bio-trans	NULL
nylon	NULL
membrane	NULL
(	NULL
ICN	NULL
,	NULL
Costa	NULL
Mesa	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
and	NULL
was	NULL
hybridized	NULL
with	NULL
species-specific	NULL
PU.1	NULL
or	NULL
Spi-B	NULL
cDNA	NULL
probes	NULL
and	NULL
18S	NULL
or	NULL
28S	NULL
rRNA	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

The	NULL
probes	NULL
for	NULL
murine	NULL
PU.1	NULL
mRNA	NULL
were	NULL
either	NULL
the	NULL
full-length	NULL
mouse	NULL
PU.1	NULL
cDNA*	NULL
``	NULL
``	NULL
or	NULL
the	NULL
most	NULL
5	NULL
'	NULL
431	NULL
bp	NULL
of	NULL
the	NULL
cDNA	NULL
(	NULL
the	NULL
Xho	NULL
I	NULL
fragment	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
for	NULL
murine	NULL
Spi-B	NULL
mRNA	NULL
was	NULL
the	NULL
5°	NULL
496-bp	NULL
Hha	NULL
I	NULL
fragment	NULL
of	NULL
the	NULL
murine	NULL
Spi-B	NULL
cDNA	NULL
(	NULL
Gonzalez	NULL
et	NULL
al	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
for	NULL
human	NULL
PU.1	NULL
mRNA	NULL
was	NULL
the	NULL
5	NULL
438	NULL
bp	NULL
(	NULL
EcoRI/Pst	NULL
I	NULL
fragment	NULL
)	NULL
of	NULL
the	NULL
human	NULL
PU.1	NULL
cDNA	NULL
.	NULL

The	NULL
probe	NULL
for	NULL
human	NULL
Spi-B	NULL
mRNA	NULL
was	NULL
the	NULL
5°	NULL
362	NULL
bp	NULL
(	NULL
the	NULL
EcoR/Nde	NULL
I	NULL
fragment	NULL
)	NULL
of	NULL
the	NULL
human	NULL
Spi-B	NULL
cDNA	NULL
.	NULL
``	NULL

The	NULL
oligonucleotide	NULL
probe	NULL
for	NULL
188	NULL
rRNA	NULL
was	NULL
bp	NULL
938	NULL
to	NULL
921	NULL
of	NULL
the	NULL
human	NULL
18S	NULL
ribosomal	NULL
RNA	NULL
-	NULL
gene	NULL
``	NULL
(	NULL
5'-TCGGGCCTGCTTTGAACA-3	NULL
``	NULL
)	NULL
.	NULL

The	NULL
oligonucleotide	NULL
for	NULL
the	NULL
28S	NULL
rRNA	NULL
was	NULL
bp	NULL
4036	NULL
to	NULL
4020	NULL
of	NULL
the	NULL
human	NULL
28S	NULL
ribosomal	NULL
RNA	NULL
``	NULL
(	NULL
5'-AGGTAGCCAAATGCCTC-3	NULL
'	NULL
)	NULL
.	NULL

188	NULL
and	NULL
288	NULL
probes	NULL
were	NULL
used	NULL
as	NULL
internal	NULL
controls	NULL
for	NULL
RNA	NULL
loading	NULL
.	NULL

The	NULL
PU.1	NULL
and	NULL
$	NULL
Spi-B	NULL
cDNA	NULL
probes	NULL
were	NULL
labeled	NULL
by	NULL
the	NULL
random	NULL
priming	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Hybridization	NULL
was	NULL
performed	NULL
at	NULL
65°C	NULL
in	NULL
0.5	NULL
mol/L	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
7	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
and	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
for	NULL
15	NULL
hours	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2920	NULL
twice	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
minutes	NULL
and	NULL
once	NULL
in	NULL
0.2	NULL
%	NULL
SSC	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
at	NULL
-80°C	NULL
with	NULL
Kodak	NULL
XAR-5	NULL
film	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
for	NULL
times	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

Subsequently	NULL
,	NULL
probes	NULL
were	NULL
removed	NULL
by	NULL
shaking	NULL
in	NULL
10	NULL
mmol/	NULL
L	NULL
sodium	NULL
phosphate	NULL
buffer	NULL
(	NULL
pH	NULL
6.5	NULL
)	NULL
and	NULL
50	NULL
%	NULL
deionized	NULL
formamide	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
65°C	NULL
,	NULL
followed	NULL
by	NULL
washing	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Blots	NULL
were	NULL
then	NULL
hybridized	NULL
to	NULL
other	NULL
cDNA	NULL
probes	NULL
or	NULL
to	NULL
the	NULL
[	NULL
«	NULL
-*	NULL
``	NULL
P	NULL
]	NULL
-deoxycytidine	NULL
triphosphate	NULL
3'-end-labeled	NULL
``	NULL
18	NULL
$	NULL
or	NULL
288	NULL
oligonucleotide	NULL
overnight	NULL
in	NULL
6	NULL
%	NULL
SSC	NULL
,	NULL
5	NULL
%	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
and	NULL
0.5	NULL
%	NULL
SDS	NULL
at	NULL
42°C	NULL
(	NULL
for	NULL
the	NULL
288	NULL
oligonucleotide	NULL
)	NULL
or	NULL
48°C	NULL
(	NULL
for	NULL
the	NULL
188	NULL
oligonucleotide	NULL
)	NULL
and	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
5	NULL
minutes	NULL
and	NULL
once	NULL
in	NULL
0.2	NULL
%	NULL
SSC	NULL
and	NULL
0.2	NULL
%	NULL
SDS	NULL
at	NULL
42°C	NULL
(	NULL
for	NULL
288	NULL
oligonucleotide	NULL
)	NULL
or	NULL
48°C	NULL
(	NULL
for	NULL
188	NULL
oligonucleotide	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
2	NULL
to	NULL
20	NULL
minutes	NULL
.	NULL

Quantitation	NULL
was	NULL
performed	NULL
on	NULL
Northern	NULL
blots	NULL
exposed	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
the	NULL
film	NULL
with	NULL
an	NULL
LKB	NULL
(	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
ultrascan	NULL
II	NULL
Densitometer	NULL
or	NULL
using	NULL
Imagequant	NULL
Phosphorimager	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Neutrophil	NULL
and	NULL
monocyte	NULL
purification	NULL
,	NULL
.	NULL

-	NULL
Peripheral	NULL
blood	NULL
(	NULL
PB	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
normal	NULL
donors	NULL
.	NULL

Dextran	NULL
T7O	NULL
(	NULL
Pharmacia	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
buffy	NULL
coat	NULL
was	NULL
collected	NULL
by	NULL
gravity	NULL
sedimentation	NULL
.	NULL

After	NULL
a	NULL
Ficoll-Hypaque	NULL
density	NULL
centrifugation	NULL
,	NULL
monocytes	NULL
were	NULL
collected	NULL
at	NULL
the	NULL
interface	NULL
and	NULL
further	NULL
purified	NULL
by	NULL
adherence	NULL
.	NULL

Neutrophils	NULL
and	NULL
red	NULL
blood	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
and	NULL
red	NULL
blood	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
0.15	NULL
mol/L	NULL
NH	NULL
,	NULL
CI	NULL
,	NULL
10	NULL
mmol/L	NULL
KHCO	NULL
;	NULL
,	NULL
and	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
for	NULL
I	NULL
to	NULL
3	NULL
minutes	NULL
.	NULL

Neutrophils	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
ice-cold	NULL
solution	NULL
of	NULL
Hanks	NULL
'	NULL
balanced	NULL
salt	NULL
solution	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
were	NULL
resuspended	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
.	NULL

Slides	NULL
of	NULL
cytocentrifuged	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
Wright-Giemsa	NULL
according	NULL
to	NULL
standard	NULL
protocol	NULL
,	NULL
and	NULL
neutrophils	NULL
were	NULL
counted	NULL
by	NULL
light	NULL
microscopy	NULL
.	NULL

This	NULL
purified	NULL
neutrophil	NULL
fraction	NULL
contained	NULL
over	NULL
94	NULL
%	NULL
mature	NULL
neutrophils	NULL
,	NULL
5	NULL
%	NULL
eo-sinophils	NULL
,	NULL
and	NULL
not	NULL
more	NULL
than	NULL
0.5	NULL
%	NULL
monocytes	NULL
.	NULL

Further	NULL
purification	NULL
of	NULL
neutrophils	NULL
was	NULL
performed	NULL
with	NULL
anti-CD16	NULL
antibody	NULL
(	NULL
MACS	NULL
CD16	NULL
Microbeads	NULL
;	NULL
Bergisch	NULL
,	NULL
Gladbach	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
magnetic	NULL
selection	NULL
.	NULL

This	NULL
fraction	NULL
was	NULL
99	NULL
%	NULL
pure	NULL
mature	NULL
neutrophils	NULL
.	NULL

Nuclear	NULL
extracts	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
grown	NULL
to	NULL
log	NULL
phase	NULL
before	NULL
harvest	NULL
for	NULL
nuclear	NULL
protein	NULL
extraction	NULL
.	NULL

Nuclear	NULL
extracts	NULL
for	NULL
electro-phoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
prepared	NULL
from	NULL
both	NULL
cell	NULL
lines	NULL
and	NULL
purified	NULL
neutrophils	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
et	NULL
al	NULL
``	NULL
with	NULL
1	NULL
mmol/L	NULL
diisopropyl	NULL
fluorophosphate	NULL
in	NULL
all	NULL
three	NULL
extraction	NULL
buffers	NULL
.	NULL

Nuclear	NULL
extracts	NULL
for	NULL
Dnase-I	NULL
footprinting	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

In	NULL
vitro	NULL
DNase-L	NULL
footprinting	NULL
.	NULL

A	NULL
370-bp	NULL
DNA	NULL
fragment	NULL
from	NULL
bp	NULL
-264	NULL
to	NULL
+106	NULL
of	NULL
the	NULL
CD1	NULL
1b	NULL
promoter	NULL
``	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
HindIII	NULL
to	NULL
release	NULL
the	NULL
promoter	NULL
fragment	NULL
from	NULL
the	NULL
vector	NULL
pGEM3Zf	NULL
(	NULL
+	NULL
)	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
was	NULL
P-labeled	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

U937	NULL
and	NULL
HL-60	NULL
cells	NULL
were	NULL
grown	NULL
to	NULL
2	NULL
x	NULL
10°/	NULL
mL	NULL
and	NULL
induced	NULL
with	NULL
either	NULL
3	NULL
x	NULL
10°	NULL
mol/L	NULL
TPA	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
24	NULL
hours	NULL
or	NULL
1	NULL
x	NULL
10°	NULL
mol/L	NULL
all-trans	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
;	NULL
Sigma	NULL
)	NULL
for	NULL
6	NULL
days	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
DNase-I	NULL
footprinting	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Nuclear	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
radio-labeled	NULL
DNA	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
ug	NULL
of	NULL
double-stranded	NULL
poly	NULL
(	NULL
dLdC	NULL
)	NULL
in	NULL
total	NULL
of	NULL
20	NULL
wL	NULL
binding	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
;	NULL
30	NULL
mmol/L	NULL
KCI	NULL
;	NULL
5	NULL
mmol/L	NULL
MgCl	NULL
;	NULL
;	NULL
1	NULL
mmol/L	NULL
dithiothreitol	NULL
;	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
;	NULL
0.4	NULL
mmol/L	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
;	NULL
12	NULL
%	NULL
glycerol	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
0°C	NULL
.	NULL

EMSA	NULL
.	NULL

-	NULL
The	NULL
probe	NULL
for	NULL
the	NULL
EMSAs	NULL
in	NULL
Fig	NULL
5	NULL
was	NULL
a	NULL
30-bp	NULL
double-stranded	NULL
oligonucleotide	NULL
representing	NULL
human	NULL
CD1	NULL
1b	NULL
promoter	NULL
bp	NULL
-26	NULL
to	NULL
+2	NULL
(	NULL
5-GCTCAAAGAAGGGCAGAAAAGGAGAAG-TAGG-3	NULL
'	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
one	NULL
PU.1	NULL
binding	NULL
site	NULL
.	NULL
``	NULL

''	NULL
The	NULL
probe	NULL
was	NULL
labeled	NULL
with	NULL
[	NULL
y-*PJadenosine	NULL
triphosphate	NULL
(	NULL
DuPont	NULL
NEN	NULL
,	NULL
Cam-bridge	NULL
,	NULL
MA	NULL
)	NULL
to	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
2	NULL
x	NULL
10	NULL
``	NULL
cpm/ug	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

'	NULL
A	NULL
total	NULL
of	NULL
0.5	NULL
ng	NULL
of	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
2	NULL
to	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
20	NULL
wL	NULL
containing	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
CHEN	NULL
ET	NULL
AL	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mmol/L	NULL
KCH	NULL
,	NULL
5	NULL
mmol/L	NULL
MgCt	NULL
:	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
mg/mL	NULL
poly	NULL
(	NULL
dLdC	NULL
)	NULL
.	NULL

0.1	NULL
mg/mL	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
5	NULL
%	NULL
glycerol	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

As	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
,	NULL
in	NULL
some	NULL
lanes	NULL
,	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
were	NULL
translated	NULL
in	NULL
vitro	NULL
using	NULL
a	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
(	NULL
TnT	NULL
system	NULL
:	NULL
;	NULL
Promega	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
,	NULL
``	NULL
and	NULL
1	NULL
pL	NULL
was	NULL
added	NULL
in	NULL
a	NULL
20-uL	NULL
reaction	NULL
instead	NULL
of	NULL
adding	NULL
nuclear	NULL
extract	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
at	NULL
100-fold	NULL
molar	NULL
excess	NULL
immediately	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radioactive	NULL
probe	NULL
.	NULL

For	NULL
supershift	NULL
experiments	NULL
,	NULL
1	NULL
gL	NULL
of	NULL
antisera	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
representing	NULL
amino	NULL
acid	NULL
33-45	NULL
of	NULL
murine	NULL
PU.1	NULL
,	NULL
against	NULL
PU.1	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
157	NULL
to	NULL
272	NULL
)	NULL
,	NULL
``	NULL
or	NULL
against	NULL
a	NULL
full-length	NULL
PU.1	NULL
protein	NULL
produced	NULL
in	NULL
bacteria	NULL
'	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
.	NULL

Reactions	NULL
were	NULL
electrophoresed	NULL
at	NULL
10	NULL
V/cm	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
(	NULL
0.5	NULL
%	NULL
TBE	NULL
(	NULL
45	NULL
mmol/L	NULL
Tris-borate	NULL
,	NULL
45	NULL
mmol/L	NULL
boric	NULL
acid	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
at	NULL
4°C	NULL
.	NULL

RESULTS	NULL
PU.1	NULL
is	NULL
expressed	NULL
in	NULL
purified	NULL
human	NULL
CD34*	NULL
cells	NULL
and	NULL
upregulated	NULL
during	NULL
commitment	NULL
to	NULL
myeloid	NULL
precursors	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
PU.1	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
hematopoiesis	NULL
has	NULL
not	NULL
been	NULL
extensively	NULL
investigated	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
relatively	NULL
scarce	NULL
number	NULL
of	NULL
CD34	NULL
*	NULL
cells	NULL
in	NULL
the	NULL
BM	NULL
,	NULL
*	NULL
we	NULL
used	NULL
RT-PCR	NULL
for	NULL
this	NULL
analysis	NULL
.	NULL

We	NULL
first	NULL
established	NULL
conditions	NULL
in	NULL
which	NULL
we	NULL
could	NULL
measure	NULL
changes	NULL
in	NULL
PU.1	NULL
expression	NULL
by	NULL
RT-PCR	NULL
in	NULL
human	NULL
CD34*	NULL
cells	NULL
.	NULL

PU.1	NULL
mRNA	NULL
is	NULL
present	NULL
in	NULL
small	NULL
amounts	NULL
in	NULL
untreated	NULL
BM	NULL
CD34	NULL
®	NULL
progenitor	NULL
cells	NULL
and	NULL
increases	NULL
twofold	NULL
by	NULL
day	NULL
1	NULL
and	NULL
10-fold	NULL
by	NULL
day	NULL
7	NULL
after	NULL
myeloid	NULL
differentiation	NULL
induced	NULL
by	NULL
GM-CSF	NULL
and	NULL
IL-3	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
PU.1	NULL
mRNA	NULL
precedes	NULL
the	NULL
increase	NULL
in	NULL
mRNA	NULL
expression	NULL
of	NULL
its	NULL
target	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
CD1	NULL
1b	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
and	NULL
Voso	NULL
et	NULL
al	NULL
'	NULL
)	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
detected	NULL
PU.1	NULL
expression	NULL
in	NULL
day-0	NULL
CD34*	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
approximately	NULL
70	NULL
%	NULL
CD34	NULL
after	NULL
a	NULL
single	NULL
immunomagnetic	NULL
selection	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
ask	NULL
whether	NULL
this	NULL
low	NULL
level	NULL
of	NULL
PU.1	NULL
mRNA	NULL
represented	NULL
expression	NULL
in	NULL
the	NULL
earliest	NULL
progenitors	NULL
or	NULL
was	NULL
a	NULL
result	NULL
of	NULL
contaminating	NULL
CD34~T	NULL
cells	NULL
.	NULL

To	NULL
answer	NULL
this	NULL
question	NULL
,	NULL
we	NULL
further	NULL
fractionated	NULL
BM	NULL
using	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
and	NULL
antibodies	NULL
to	NULL
CD34	NULL
and	NULL
CD38	NULL
.	NULL

Previously	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
CD34*/CD38~	NULL
cells	NULL
represent	NULL
a	NULL
more	NULL
primitive	NULL
population	NULL
that	NULL
differentiates	NULL
into	NULL
a	NULL
CD34*/CD38*	NULL
and	NULL
,	NULL
subsequently	NULL
,	NULL
to	NULL
a	NULL
CD34~	NULL
population	NULL
,	NULL
during	NULL
which	NULL
time	NULL
GATA-1	NULL
mRNA	NULL
,	NULL
undetectable	NULL
in	NULL
CD34*/CD38~	NULL
cells	NULL
,	NULL
increases	NULL
.	NULL
``	NULL

''	NULL
When	NULL
we	NULL
fractionated	NULL
BM	NULL
in	NULL
this	NULL
manner	NULL
,	NULL
we	NULL
could	NULL
still	NULL
detect	NULL
PU.1	NULL
mRNA	NULL
in	NULL
the	NULL
CD34*/CD38~	NULL
fraction	NULL
,	NULL
although	NULL
it	NULL
was	NULL
increased	NULL
in	NULL
the	NULL
more	NULL
mature	NULL
CD34~	NULL
fraction	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
the	NULL
expression	NULL
of	NULL
PU.1	NULL
mRNA	NULL
in	NULL
primitive	NULL
progenitor	NULL
cell	NULL
populations	NULL
.	NULL

PU.1	NULL
but	NULL
not	NULL
Spi-B	NULL
is	NULL
upregulated	NULL
during	NULL
myeloid	NULL
commitment	NULL
of	NULL
murine	NULL
multipotential	NULL
cells	NULL
.	NULL

-	NULL
To	NULL
confirm	NULL
our	NULL
results	NULL
showing	NULL
that	NULL
PU.1	NULL
is	NULL
upregulated	NULL
during	NULL
multipotential	NULL
progenitor	NULL
commitment	NULL
,	NULL
we	NULL
used	NULL
a	NULL
cell	NULL
line	NULL
model	NULL
of	NULL
early	NULL
hematopoietic	NULL
development	NULL
.	NULL

FDCP-mix	NULL
A4	NULL
cells	NULL
are	NULL
a	NULL
multi-potential	NULL
,	NULL
diploid	NULL
,	NULL
nonleukemic	NULL
,	NULL
nontransformed	NULL
murine	NULL
BM	NULL
cell	NULL
line	NULL
that	NULL
can	NULL
be	NULL
induced	NULL
into	NULL
different	NULL
lineages	NULL
with	NULL
specific	NULL
CSFs	NULL
.	NULL

``	NULL
°	NULL
When	NULL
we	NULL
induced	NULL
FDCP-mix	NULL
A4	NULL
with	NULL
GM-CSF	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
low	NULL
doses	NULL
of	NULL
IL-3	NULL
,	NULL
the	NULL
cells	NULL
differentiated	NULL
from	NULL
blast-like	NULL
morphology	NULL
with	NULL
less	NULL
than	NULL
10	NULL
%	NULL
monocytes	NULL
on	NULL
day	NULL
1	NULL
to	NULL
90	NULL
%	NULL
macrophage-like	NULL
cells	NULL
on	NULL
day	NULL
5	NULL
.	NULL

We	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PU.1	NULL
AND	NULL
Spi-B	NULL
EXPRESSION	NULL
IN	NULL
MYELOID	NULL
CELLS	NULL
found	NULL
,	NULL
as	NULL
reported	NULL
previously	NULL
,	NULL
'	NULL
``	NULL
that	NULL
PU.1	NULL
mRNA	NULL
is	NULL
expressed	NULL
in	NULL
FDCP-mix	NULL
A4	NULL
cells	NULL
.	NULL

We	NULL
detected	NULL
a	NULL
very	NULL
low	NULL
level	NULL
of	NULL
PU.1	NULL
mRNA	NULL
in	NULL
undifferentiated	NULL
day-0	NULL
FDCP-mix	NULL
cells	NULL
,	NULL
which	NULL
increased	NULL
in	NULL
association	NULL
with	NULL
this	NULL
monocytic	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
5'-specific	NULL
probe	NULL
for	NULL
murine	NULL
Spi-B	NULL
,	NULL
we	NULL
detected	NULL
no	NULL
expression	NULL
of	NULL
Spi-B	NULL
mRNA	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
even	NULL
after	NULL
monocytic	NULL
differentiation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

PU.1	NULL
expression	NULL
is	NULL
maintained	NULL
during	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cell	NULL
lines	NULL
.	NULL

-	NULL
The	NULL
demonstration	NULL
of	NULL
significant	NULL
upregulation	NULL
of	NULL
PU.1	NULL
mRNA	NULL
during	NULL
the	NULL
commitment	NULL
of	NULL
multipotential	NULL
progenitors	NULL
to	NULL
the	NULL
myeloid	NULL
lineage	NULL
led	NULL
us	NULL
to	NULL
ask	NULL
the	NULL
question	NULL
of	NULL
what	NULL
happens	NULL
to	NULL
PU.1	NULL
mRNA	NULL
during	NULL
the	NULL
next	NULL
stage	NULL
of	NULL
myeloid	NULL
differentiation	NULL
,	NULL
from	NULL
promyelocytic	NULL
to	NULL
neutrophilic	NULL
cells	NULL
.	NULL

For	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
used	NULL
RA	NULL
treatment	NULL
of	NULL
HL-60	NULL
and	NULL
U937	NULL
cells	NULL
as	NULL
a	NULL
model	NULL
.	NULL
``	NULL

''	NULL
In	NULL
the	NULL
uninduced	NULL
state	NULL
,	NULL
these	NULL
cells	NULL
represent	NULL
promyelocytic/promonocytic	NULL
cells	NULL
.	NULL

Addition	NULL
of	NULL
10~°	NULL
mol/L	NULL
RA	NULL
induces	NULL
neutrophilic	NULL
differentiation	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
morphology	NULL
and	NULL
upregulation	NULL
of	NULL
markers	NULL
such	NULL
as	NULL
CD18	NULL
.	NULL
``	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
no	NULL
significant	NULL
change	NULL
in	NULL
PU.1	NULL
mRNA	NULL
levels	NULL
during	NULL
RA	NULL
induction	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
to	NULL
show	NULL
that	NULL
we	NULL
,	NULL
indeed	NULL
,	NULL
induced	NULL
differentiation	NULL
,	NULL
analysis	NULL
of	NULL
the	NULL
same	NULL
RNA	NULL
preparations	NULL
showed	NULL
that	NULL
CD18	NULL
mRNA	NULL
increased	NULL
significantly	NULL
during	NULL
RA	NULL
induction	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Although	NULL
PU.1	NULL
mRNA	NULL
does	NULL
not	NULL
change	NULL
in	NULL
a	NULL
significant	NULL
way	NULL
during	NULL
RA-induced	NULL
neutrophilic	NULL
differentiation	NULL
of	NULL
HL60	NULL
or	NULL
U937	NULL
cell	NULL
lines	NULL
,	NULL
it	NULL
is	NULL
still	NULL
possible	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
PU.1	NULL
protein	NULL
changes	NULL
through	NULL
posttranscriptional	NULL
regulation	NULL
or	NULL
alterations	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

To	NULL
assess	NULL
PU.1	NULL
DNA	NULL
binding	NULL
activity	NULL
during	NULL
myeloid	NULL
differentiation	NULL
,	NULL
we	NULL
performed	NULL
DNAse-I	NULL
protection	NULL
of	NULL
a	NULL
CD11b	NULL
promoter	NULL
fragment	NULL
PU.1	NULL
binding	NULL
site	NULL
,	NULL
comparing	NULL
the	NULL
difference	NULL
between	NULL
uninduced	NULL
and	NULL
RA-	NULL
or	NULL
TPA-induced	NULL
U937	NULL
and	NULL
HL-60	NULL
nuclear	NULL
extracts	NULL
.	NULL

We	NULL
could	NULL
detect	NULL
no	NULL
significant	NULL
difference	NULL
between	NULL
CD34	NULL
*F	NULL
+	NULL
ae	NULL
CD38	NULL
-	NULL
p	NULL
PU.1	NULL
GAPDH	NULL
PU.1	NULL
/	NULL
GAPDH	NULL
Ratio	NULL
1	NULL
1	NULL
4	NULL
Fig	NULL
1	NULL
.	NULL

_	NULL
PU.1	NULL
expression	NULL
in	NULL
human	NULL
CD34*/CD38~	NULL
,	NULL
CD34*/CD38®	NULL
,	NULL
and	NULL
CD34~	NULL
cells	NULL
.	NULL

Human	NULL
BM	NULL
nonadherent	NULL
light	NULL
density	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
into	NULL
CD34*/CD38~	NULL
,	NULL
CD34*/CD38°	NULL
,	NULL
and	NULL
CD34~	NULL
populations	NULL
,	NULL
and	NULL
amplification	NULL
by	NULL
RT-PCR	NULL
and	NULL
hybridization	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
third	NULL
lane	NULL
contains	NULL
CD34~	NULL
cells	NULL
,	NULL
including	NULL
both	NULL
CD38	NULL
and	NULL
CD38~	NULL
poplulations	NULL
.	NULL

The	NULL
relative	NULL
PU.1/GAPDH	NULL
ratio	NULL
,	NULL
determined	NULL
by	NULL
scanning	NULL
densitometry	NULL
,	NULL
is	NULL
shown	NULL
under	NULL
the	NULL
autoradiograph	NULL
.	NULL

2921	NULL
GM-CSF	NULL
day	NULL
-	NULL
0	NULL
1	NULL
3	NULL
5	NULL
-	NULL
288	NULL
-	NULL
188	NULL
PU.1	NULL
-	NULL
«	NULL
aw	NULL
ce	NULL
288	NULL
--	NULL
PU.1	NULL
288	NULL
1	NULL
2.2	NULL
4.9	NULL
16	NULL
Fig	NULL
2	NULL
.	NULL

PU.1	NULL
expression	NULL
during	NULL
myeloid	NULL
differentiation	NULL
of	NULL
murine	NULL
multipotential	NULL
progenitor	NULL
FDCP-mix	NULL
A4	NULL
cells	NULL
.	NULL

FDCP-mix	NULL
A4	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
GM-CSF	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
low	NULL
doses	NULL
of	NULL
IL-3	NULL
and	NULL
were	NULL
harvested	NULL
at	NULL
the	NULL
days	NULL
indicated	NULL
to	NULL
extract	NULL
RNA	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
upper	NULL
panel	NULL
shows	NULL
the	NULL
blot	NULL
hybridized	NULL
with	NULL
the	NULL
1.4-kb	NULL
murine	NULL
PU.1	NULL
cDNA	NULL
;	NULL
the	NULL
lower	NULL
panel	NULL
shows	NULL
hybridization	NULL
to	NULL
a	NULL
28S	NULL
oligonucleotide	NULL
,	NULL
which	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
for	NULL
RNA	NULL
loading	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
in	NULL
PU.1	NULL
mRNA	NULL
,	NULL
normalized	NULL
for	NULL
28	NULL
$	NULL
signal	NULL
,	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Each	NULL
lane	NULL
contained	NULL
10	NULL
mg	NULL
total	NULL
RNA	NULL
,	NULL
and	NULL
autoradiography	NULL
with	NULL
the	NULL
PU.1	NULL
probe	NULL
was	NULL
performed	NULL
for	NULL
24	NULL
hours	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

PU.1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
uninduced	NULL
or	NULL
induced	NULL
nuclear	NULL
extracts	NULL
in	NULL
either	NULL
cell	NULL
line	NULL
,	NULL
with	NULL
either	NULL
monocytic	NULL
(	NULL
TPA	NULL
)	NULL
or	NULL
neutrophilic	NULL
(	NULL
RA	NULL
)	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
these	NULL
results	NULL
,	NULL
combined	NULL
with	NULL
our	NULL
mRNA	NULL
expression	NULL
studies	NULL
,	NULL
suggest	NULL
that	NULL
PU.1	NULL
is	NULL
upregulated	NULL
during	NULL
the	NULL
process	NULL
of	NULL
stem	NULL
cell/multipotential	NULL
progenitor	NULL
cell	NULL
differentiation	NULL
to	NULL
myeloid	NULL
precursors	NULL
and	NULL
is	NULL
not	NULL
downregulated	NULL
during	NULL
differentiation	NULL
of	NULL
myeloid	NULL
precursors	NULL
to	NULL
neutrophilic	NULL
and/or	NULL
monocytic	NULL
cells	NULL
.	NULL

PU.1	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
mature	NULL
human	NULL
neutrophils	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
PU.1	NULL
mRNA	NULL
and	NULL
protein	NULL
was	NULL
not	NULL
downregulated	NULL
during	NULL
neutrophilic	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
might	NULL
be	NULL
expressed	NULL
in	NULL
human	NULL
neutrophils	NULL
at	NULL
significant	NULL
levels	NULL
.	NULL

Furthermore	NULL
,	NULL
PU	NULL
.	NULL

1	NULL
is	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
the	NULL
CD1	NULL
1b	NULL
promoter	NULL
,	NULL
and	NULL
neutrophils	NULL
,	NULL
like	NULL
monocytes	NULL
,	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
CD1Mb	NULL
.	NULL

*	NULL
``	NULL
~	NULL
``	NULL
Therefore	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
neutrophils	NULL
,	NULL
like	NULL
monocytes	NULL
,	NULL
expressed	NULL
PU.1	NULL
mRNA	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
with	NULL
a	NULL
full-length	NULL
mouse	NULL
PU.1	NULL
cDNA	NULL
probe	NULL
showed	NULL
that	NULL
human	NULL
PB	NULL
neutrophils	NULL
expressed	NULL
significant	NULL
levels	NULL
of	NULL
PU.1	NULL
mRNA	NULL
,	NULL
approximately	NULL
twice	NULL
that	NULL
of	NULL
human	NULL
PB	NULL
monocytes	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2922	NULL
U937	NULL
HL60	NULL
CHEN	NULL
ET	NULL
AL	NULL
|	NULL
I	NULL
|	NULL
RA	NULL
treatment	NULL
,	NULL
hr	NULL
0	NULL
8	NULL
24	NULL
48	NULL
72	NULL
PU.1	NULL
_	NULL
--	NULL
>	NULL
CD18	NULL
--	NULL
>	NULL
288	NULL
_	NULL
--	NULL
>	NULL
HeLa	NULL
cell	NULL
RNA	NULL
showed	NULL
no	NULL
expression	NULL
of	NULL
PU.1	NULL
,	NULL
a	NULL
result	NULL
similar	NULL
to	NULL
our	NULL
inability	NULL
to	NULL
detect	NULL
PU.1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
.	NULL
``	NULL

Using	NULL
a	NULL
specific	NULL
5	NULL
'	NULL
human	NULL
PU.1	NULL
cDNA	NULL
probe	NULL
on	NULL
Northern	NULL
blots	NULL
confirmed	NULL
that	NULL
human	NULL
neutrophils	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
PU.1	NULL
mRNA	NULL
,	NULL
higher	NULL
than	NULL
that	NULL
observed	NULL
in	NULL
human	NULL
myeloid	NULL
lines	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

To	NULL
show	NULL
that	NULL
human	NULL
neutrophils	NULL
also	NULL
synthesized	NULL
functional	NULL
PU.1	NULL
protein	NULL
,	NULL
we	NULL
performed	NULL
EMSA	NULL
using	NULL
neutrophil	NULL
nuclear	NULL
extracts	NULL
.	NULL

We	NULL
first	NULL
determined	NULL
the	NULL
ability	NULL
of	NULL
two	NULL
different	NULL
PU.1	NULL
antisera	NULL
to	NULL
supershift	NULL
specific	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
com-plexes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5A	NULL
,	NULL
antisera	NULL
raised	NULL
against	NULL
a	NULL
PU.1	NULL
amino	NULL
terminal	NULL
peptide	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
and	NULL
poly-clonal	NULL
antiserum	NULL
raised	NULL
against	NULL
full-length	NULL
PU.1	NULL
protein	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
specifically	NULL
supershifted	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
but	NULL
not	NULL
Spi-B	NULL
,	NULL
although	NULL
both	NULL
proteins	NULL
bound	NULL
well	NULL
to	NULL
the	NULL
CD11b	NULL
PU.1	NULL
site	NULL
probe	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
same	NULL
amino	NULL
terminal	NULL
antibody	NULL
supershifted	NULL
nearly	NULL
all	NULL
of	NULL
the	NULL
full-length	NULL
PU.1	NULL
protein	NULL
in	NULL
U937	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
but	NULL
did	NULL
not	NULL
supershift	NULL
the	NULL
faster	NULL
migrating	NULL
species	NULL
(	NULL
A*	NULL
)	NULL
we	NULL
previously	NULL
described	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
``	NULL
``	NULL
which	NULL
is	NULL
a	NULL
carboxyl-terminal	NULL
cleavage	NULL
product	NULL
that	NULL
retains	NULL
the	NULL
PU.1	NULL
DNA	NULL
binding	NULL
domain	NULL
but	NULL
has	NULL
lost	NULL
the	NULL
amino-terminal	NULL
peptide	NULL
sequence	NULL
that	NULL
reacts	NULL
with	NULL
the	NULL
amino-terminal	NULL
antiserum	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
antiserum	NULL
against	NULL
full-length	NULL
PU.1	NULL
supershifted	NULL
both	NULL
complexes	NULL
in	NULL
U937	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
16	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
both	NULL
antisera	NULL
specifically	NULL
recognize	NULL
PU.1	NULL
and	NULL
not	NULL
Spi-B	NULL
and	NULL
that	NULL
U937	NULL
myeloid	NULL
cell	NULL
extracts	NULL
contain	NULL
little	NULL
or	NULL
no	NULL
Spi-B	NULL
DNA	NULL
binding	NULL
protein	NULL
.	NULL

A	NULL
third	NULL
antisera	NULL
,	NULL
raised	NULL
against	NULL
the	NULL
PU.1	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
reacting	NULL
with	NULL
PU.1	NULL
but	NULL
not	NULL
Spi-B	NULL
,	NULL
``	NULL
also	NULL
abolishes	NULL
all	NULL
of	NULL
the	NULL
specific	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
U937	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
17	NULL
and	NULL
18	NULL
)	NULL
.	NULL

When	NULL
this	NULL
same	NULL
CD11b	NULL
probe	NULL
was	NULL
used	NULL
with	NULL
neutrophil	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
,	NULL
we	NULL
failed	NULL
to	NULL
observe	NULL
a	NULL
full-length	NULL
PU.1	NULL
complex	NULL
formed	NULL
by	NULL
either	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
1	NULL
;	NULL
Fig	NULL
5B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
20	NULL
)	NULL
or	NULL
the	NULL
slowest	NULL
migrating	NULL
species	NULL
in	NULL
U937	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
9	NULL
and	NULL
13	NULL
;	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
4	NULL
;	NULL
complex	NULL
``	NULL
S	NULL
``	NULL
)	NULL
.	NULL

We	NULL
did	NULL
observe	NULL
small	NULL
amounts	NULL
of	NULL
specific	NULL
complex	NULL
A*	NULL
found	NULL
in	NULL
some	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
9	NULL
and	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
but	NULL
not	NULL
all	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
17	NULL
)	NULL
preparations	NULL
of	NULL
ee	NULL
_	NULL
``	NULL
T	NULL
``	NULL
_	NULL
-	NULL
288	NULL
-188	NULL
0	NULL
8	NULL
24	NULL
48	NULL
72	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
PU.1	NULL
expression	NULL
during	NULL
U937	NULL
and	NULL
HL-60	NULL
differentiation	NULL
.	NULL

Promyelocytic	NULL
HL-60	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
1	NULL
x	NULL
10°	NULL
mol/L	NULL
all-trans	NULL
RA	NULL
for	NULL
the	NULL
duration	NULL
specified	NULL
in	NULL
hours	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10	NULL
ug	NULL
of	NULL
each	NULL
RNA	NULL
sample	NULL
was	NULL
resolved	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
probed	NULL
with	NULL
a	NULL
1.4-kb	NULL
PU.1	NULL
cDNA	NULL
fragment	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
,	NULL
CD18	NULL
cDNA*	NULL
(	NULL
middle	NULL
panel	NULL
)	NULL
,	NULL
and	NULL
28S	NULL
RNA	NULL
oligonucleotide	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
for	NULL
120	NULL
hours	NULL
with	NULL
the	NULL
PU.1	NULL
probe	NULL
and	NULL
for	NULL
24	NULL
hours	NULL
with	NULL
the	NULL
CD18	NULL
probe	NULL
.	NULL

-288	NULL
-188	NULL
U937	NULL
cells	NULL
.	NULL

Significantly	NULL
,	NULL
in	NULL
neutrophils	NULL
we	NULL
also	NULL
observed	NULL
an	NULL
even	NULL
faster	NULL
migrating	NULL
specific	NULL
complex	NULL
(	NULL
*N	NULL
;	NULL
Fig	NULL
5B	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
13	NULL
)	NULL
that	NULL
was	NULL
competed	NULL
specifically	NULL
with	NULL
oligonucleotides	NULL
known	NULL
to	NULL
bind	NULL
PU.1	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lanes	NULL
8	NULL
,	NULL
10	NULL
and	NULL
14	NULL
)	NULL
but	NULL
not	NULL
with	NULL
mutant	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lanes	NULL
9	NULL
and	NULL
15	NULL
)	NULL
or	NULL
irrelevant	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
oligonucleotide	NULL
competitors	NULL
.	NULL

Complex	NULL
N	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
addition	NULL
of	NULL
the	NULL
amino-terminal	NULL
PU.1	NULL
peptide	NULL
antibody	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
or	NULL
by	NULL
an	NULL
anti-Oct	NULL
antisera	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnologies	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
addition	NULL
of	NULL
the	NULL
full-length	NULL
PU.1	NULL
antiserum	NULL
abolished	NULL
the	NULL
complex	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
16	NULL
)	NULL
and	NULL
increased	NULL
the	NULL
amount	NULL
of	NULL
radioactivity	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
gel	NULL
,	NULL
which	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
and	NULL
U937	NULL
nuclear	NULL
extract	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
16	NULL
)	NULL
.	NULL

Antiserum	NULL
raised	NULL
against	NULL
the	NULL
PU.1	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
previously	NULL
shown	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
PU.1	NULL
and	NULL
not	NULL
recognizing	NULL
Spi-B	NULL
,	NULL
``	NULL
almost	NULL
completely	NULL
abolished	NULL
complex	NULL
N	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
18	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
complex	NULL
N	NULL
in	NULL
Fig	NULL
5B	NULL
represents	NULL
a	NULL
cleaved	NULL
form	NULL
of	NULL
PU.1	NULL
found	NULL
in	NULL
human	NULL
neutrophils	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
we	NULL
can	NULL
generate	NULL
a	NULL
complex	NULL
migrating	NULL
with	NULL
identical	NULL
mobility	NULL
from	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
protein	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
neutrophil	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lanes	NULL
19	NULL
and	NULL
21	NULL
)	NULL
.	NULL

Spi-B	NULL
is	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
not	NULL
at	NULL
significant	NULL
levels	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

_	NULL
Northern	NULL
blots	NULL
using	NULL
a	NULL
full-length	NULL
human	NULL
Spi-B	NULL
cDNA	NULL
probe	NULL
had	NULL
indicated	NULL
that	NULL
Spi-B	NULL
was	NULL
expressed	NULL
at	NULL
levels	NULL
comparable	NULL
with	NULL
that	NULL
of	NULL
PU.1	NULL
in	NULL
both	NULL
myeloid	NULL
and	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

However	NULL
,	NULL
this	NULL
finding	NULL
was	NULL
in	NULL
conflict	NULL
with	NULL
our	NULL
previous	NULL
supershift	NULL
studies	NULL
in	NULL
myeloid	NULL
lines	NULL
,	NULL
``	NULL
``	NULL
in	NULL
which	NULL
the	NULL
amino	NULL
terminal	NULL
PU.1	NULL
peptide	NULL
antibody	NULL
,	NULL
which	NULL
recognizes	NULL
PU.1	NULL
and	NULL
not	NULL
Spi-B	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
was	NULL
capable	NULL
of	NULL
supershift-ing	NULL
almost	NULL
all	NULL
of	NULL
the	NULL
PU.1/Spi-B	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
12	NULL
,	NULL
and	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

We	NULL
have	NULL
observed	NULL
similar	NULL
findings	NULL
in	NULL
myeloid	NULL
THP-1	NULL
cells	NULL
.	NULL
``	NULL

Because	NULL
Spi-B	NULL
binds	NULL
to	NULL
sites	NULL
such	NULL
as	NULL
the	NULL
CD11b	NULL
PU.1	NULL
site	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
then	NULL
,	NULL
if	NULL
Spi-B	NULL
is	NULL
expressed	NULL
at	NULL
significant	NULL
levels	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
we	NULL
would	NULL
expect	NULL
a	NULL
significant	NULL
residual	NULL
Spi-B	NULL
complex	NULL
in	NULL
EMSA	NULL
using	NULL
U937	NULL
extracts	NULL
,	NULL
which	NULL
is	NULL
,	NULL
however	NULL
,	NULL
not	NULL
observed	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
12	NULL
,	NULL
16	NULL
,	NULL
and	NULL
18	NULL
;	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PU.1	NULL
AND	NULL
Spi-B	NULL
EXPRESSION	NULL
IN	NULL
MYELOID	NULL
CELLS	NULL
C	NULL
H	NULL
MN	NULL
PU.1	NULL
188	NULL
|	NULL
§	NULL
Lj	NULL
L3	NULL
joue	NULL
b	NULL
>	NULL
Uo	NULL
Mono	NULL
Mac	NULL
6	NULL
(	NULL
human	NULL
monocytic	NULL
)	NULL
HeLa	NULL
(	NULL
human	NULL
epithelial	NULL
)	NULL
U937	NULL
(	NULL
human	NULL
myeloid	NULL
)	NULL
Jurkat	NULL
(	NULL
human	NULL
T	NULL
)	NULL
BJA-B	NULL
(	NULL
human	NULL
B	NULL
)	NULL
RAJI	NULL
(	NULL
human	NULL
B	NULL
)	NULL
Neutrophil	NULL
(	NULL
human	NULL
)	NULL
Monocyte	NULL
(	NULL
human	NULL
)	NULL
HL60	NULL
(	NULL
human	NULL
myeloid	NULL
)	NULL
K-562	NULL
(	NULL
human	NULL
CML	NULL
)	NULL
-	NULL
288	NULL
HUMAN	NULL
PU.1	NULL
-	NULL
--	NULL
188	NULL
®	NULL
~	NULL
#	NULL
ge	NULL
-s	NULL
a	NULL
»	NULL
A	NULL
#	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
Fig	NULL
4	NULL
.	NULL

PU.1	NULL
expression	NULL
in	NULL
PB	NULL
monocytes	NULL
,	NULL
neutrophils	NULL
,	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Comparative	NULL
expression	NULL
of	NULL
PU.1	NULL
in	NULL
human	NULL
PB	NULL
monocytes	NULL
and	NULL
neutrophils	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
northern	NULL
blot	NULL
was	NULL
hybridized	NULL
to	NULL
the	NULL
1.4-kb	NULL
human	NULL
PU.1	NULL
cDNA	NULL
.	NULL
``	NULL

Lane	NULL
1	NULL
,	NULL
HeLa	NULL
(	NULL
epithelial	NULL
cell	NULL
line	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
mature	NULL
PB	NULL
monocytes	NULL
;	NULL
and	NULL
lane	NULL
3	NULL
,	NULL
neutrophils	NULL
.	NULL

The	NULL
purified	NULL
monocyte	NULL
fraction	NULL
contains	NULL
approximately	NULL
10	NULL
%	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
do	NULL
not	NULL
express	NULL
PU.1°	NULL
``	NULL
;	NULL
whereas	NULL
the	NULL
neutrophil	NULL
fraction	NULL
contained	NULL
5	NULL
%	NULL
eosino-phils	NULL
and	NULL
less	NULL
than	NULL
0.5	NULL
%	NULL
monocytes	NULL
.	NULL

Each	NULL
lane	NULL
contained	NULL
10	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
and	NULL
autoradiography	NULL
was	NULL
performed	NULL
for	NULL
24	NULL
hours	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

The	NULL
bottom	NULL
panel	NULL
shows	NULL
the	NULL
18S	NULL
oligonucleotide	NULL
hybridization	NULL
,	NULL
which	NULL
was	NULL
used	NULL
to	NULL
normalize	NULL
loading	NULL
of	NULL
RNA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparative	NULL
expression	NULL
of	NULL
PU.1	NULL
in	NULL
human	NULL
PB	NULL
monocytes	NULL
,	NULL
neutrophils	NULL
,	NULL
and	NULL
cell	NULL
lines	NULL
is	NULL
shown	NULL
.	NULL

Northern	NULL
analysis	NULL
of	NULL
human	NULL
cells	NULL
and	NULL
cell	NULL
lines	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
4A	NULL
,	NULL
except	NULL
the	NULL
specific	NULL
5°	NULL
438-bp	NULL
human	NULL
PU.1	NULL
cDNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Each	NULL
lane	NULL
contained	NULL
10	NULL
mg	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
and	NULL
autoradiography	NULL
was	NULL
performed	NULL
for	NULL
12	NULL
hours	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
.	NULL

Lane	NULL
5	NULL
contains	NULL
a	NULL
neutrophil	NULL
fraction	NULL
further	NULL
enriched	NULL
by	NULL
immunomagnetic	NULL
selection	NULL
with	NULL
anti-CD16	NULL
antibodies	NULL
(	NULL
99	NULL
%	NULL
neu-trophils	NULL
)	NULL
.	NULL

Although	NULL
lane	NULL
5	NULL
is	NULL
relatively	NULL
underloaded	NULL
(	NULL
note	NULL
the	NULL
weak	NULL
18S	NULL
signal	NULL
)	NULL
,	NULL
nevertheless	NULL
,	NULL
we	NULL
observe	NULL
a	NULL
significant	NULL
amount	NULL
of	NULL
PU.1	NULL
mRNA	NULL
.	NULL

2923	NULL
To	NULL
more	NULL
accurately	NULL
assess	NULL
the	NULL
differential	NULL
expression	NULL
of	NULL
Spi-B	NULL
in	NULL
comparison	NULL
with	NULL
PU.1	NULL
on	NULL
Northern	NULL
blots	NULL
,	NULL
we	NULL
used	NULL
5	NULL
'	NULL
human	NULL
and	NULL
murine	NULL
cDNA	NULL
probes	NULL
for	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
.	NULL

Figure	NULL
6A	NULL
shows	NULL
the	NULL
DNA	NULL
sequence	NULL
comparisons	NULL
between	NULL
murine	NULL
and	NULL
human	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
cDNAs	NULL
.	NULL

The	NULL
similarity	NULL
of	NULL
the	NULL
5	NULL
``	NULL
cDNA	NULL
regions	NULL
used	NULL
as	NULL
specific	NULL
probes	NULL
for	NULL
murine	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
is	NULL
48	NULL
%	NULL
,	NULL
whereas	NULL
that	NULL
of	NULL
the	NULL
3	NULL
'	NULL
DNA	NULL
binding	NULL
regions	NULL
is	NULL
70	NULL
%	NULL
.	NULL

For	NULL
human	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
,	NULL
the	NULL
similarity	NULL
of	NULL
the	NULL
5	NULL
probes	NULL
is	NULL
52	NULL
%	NULL
,	NULL
whereas	NULL
that	NULL
of	NULL
the	NULL
3	NULL
'	NULL
DNA	NULL
binding	NULL
regions	NULL
is	NULL
75	NULL
%	NULL
.	NULL

Figure	NULL
6B	NULL
shows	NULL
the	NULL
species	NULL
similarity	NULL
between	NULL
human	NULL
and	NULL
murine	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
cDNAs	NULL
.	NULL

Again	NULL
,	NULL
the	NULL
similarity	NULL
is	NULL
higher	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
domains	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
full	NULL
length	NULL
probes	NULL
which	NULL
include	NULL
the	NULL
highly	NULL
conserved	NULL
carboxyl-terminal	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
these	NULL
5	NULL
'	NULL
probes	NULL
distinguish	NULL
between	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
and	NULL
also	NULL
show	NULL
species	NULL
specificity	NULL
in	NULL
that	NULL
murine	NULL
probes	NULL
do	NULL
not	NULL
cross-react	NULL
with	NULL
human	NULL
mRNA	NULL
and	NULL
vice	NULL
versa	NULL
(	NULL
see	NULL
Fig	NULL
7	NULL
and	NULL
discussed	NULL
below	NULL
)	NULL
.	NULL

When	NULL
these	NULL
gene-	NULL
and	NULL
species-specific	NULL
probes	NULL
were	NULL
used	NULL
,	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
showed	NULL
a	NULL
very	NULL
different	NULL
pattern	NULL
of	NULL
expression	NULL
,	NULL
both	NULL
in	NULL
human	NULL
and	NULL
murine	NULL
cells	NULL
.	NULL

Human	NULL
Spi-B	NULL
was	NULL
expressed	NULL
only	NULL
in	NULL
a	NULL
human	NULL
pro-B-cell	NULL
line	NULL
,	NULL
BJA-B	NULL
,	NULL
and	NULL
was	NULL
not	NULL
expressed	NULL
in	NULL
three	NULL
myeloid	NULL
cell	NULL
lines	NULL
that	NULL
are	NULL
strongly	NULL
positive	NULL
for	NULL
PU.1	NULL
mRNA	NULL
(	NULL
Fig	NULL
7A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
could	NULL
detect	NULL
no	NULL
hybridization	NULL
of	NULL
the	NULL
human	NULL
Spi-B	NULL
probe	NULL
to	NULL
human	NULL
PB	NULL
neutrophil	NULL
mRNA	NULL
using	NULL
the	NULL
blots	NULL
shown	NULL
in	NULL
Fig	NULL
4	NULL
,	NULL
although	NULL
a	NULL
strong	NULL
signal	NULL
was	NULL
detected	NULL
in	NULL
BJA-B	NULL
cells	NULL
in	NULL
Fig	NULL
4B	NULL
,	NULL
lane	NULL
3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
our	NULL
EMSA	NULL
data	NULL
,	NULL
in	NULL
which	NULL
little	NULL
or	NULL
no	NULL
DNA	NULL
binding	NULL
Spi-B	NULL
protein	NULL
was	NULL
observed	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
12	NULL
,	NULL
16	NULL
,	NULL
and	NULL
18	NULL
;	NULL
Fig	NULL
5B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

In	NULL
the	NULL
B-cell	NULL
line	NULL
,	NULL
we	NULL
did	NULL
detect	NULL
three	NULL
human	NULL
Spi-B	NULL
mRNA	NULL
species	NULL
(	NULL
Fig	NULL
7B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
including	NULL
(	NULL
1	NULL
)	NULL
a	NULL
predominant	NULL
1.4-kb	NULL
form	NULL
,	NULL
which	NULL
comigrates	NULL
with	NULL
the	NULL
single	NULL
PU.1	NULL
mRNA	NULL
species	NULL
;	NULL
(	NULL
2	NULL
)	NULL
a	NULL
minor	NULL
5-kb	NULL
form	NULL
,	NULL
which	NULL
migrates	NULL
just	NULL
below	NULL
the	NULL
28S	NULL
rRNA	NULL
;	NULL
and	NULL
(	NULL
3	NULL
)	NULL
a	NULL
barely	NULL
detectable	NULL
3-kb	NULL
form	NULL
running	NULL
between	NULL
the	NULL
288	NULL
and	NULL
188	NULL
rRNA	NULL
bands	NULL
.	NULL

These	NULL
probes	NULL
were	NULL
also	NULL
species-specific	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
human	NULL
5	NULL
'	NULL
Spi-B	NULL
probe	NULL
failed	NULL
to	NULL
detect	NULL
murine	NULL
Spi-B	NULL
mRNA	NULL
present	NULL
in	NULL
abundance	NULL
in	NULL
murine	NULL
B-cell	NULL
lines	NULL
(	NULL
compare	NULL
Fig	NULL
7A	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
9	NULL
[	NULL
upper	NULL
panel	NULL
]	NULL
,	NULL
with	NULL
Fig	NULL
7B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
[	NULL
upper	NULL
panel	NULL
}	NULL
)	NULL
.	NULL

The	NULL
human	NULL
PU.1	NULL
5	NULL
'	NULL
probe	NULL
detected	NULL
a	NULL
single	NULL
1.4-kb	NULL
species	NULL
in	NULL
human	NULL
myeloid	NULL
and	NULL
B-cell	NULL
lines	NULL
and	NULL
did	NULL
not	NULL
significantly	NULL
cross-react	NULL
with	NULL
murine	NULL
PU.1	NULL
mRNA	NULL
under	NULL
the	NULL
conditions	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
(	NULL
Fig	NULL
7A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
murine	NULL
lines	NULL
and	NULL
tissues	NULL
with	NULL
specific	NULL
5	NULL
'	NULL
murine	NULL
probes	NULL
for	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
showed	NULL
a	NULL
similar	NULL
lack	NULL
of	NULL
significant	NULL
levels	NULL
of	NULL
Spi-B	NULL
expression	NULL
in	NULL
myeloid	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
findings	NULL
in	NULL
human	NULL
cells	NULL
(	NULL
Fig	NULL
7B	NULL
)	NULL
.	NULL

Murine	NULL
Spi-B	NULL
was	NULL
detected	NULL
only	NULL
as	NULL
a	NULL
single	NULL
3-kb	NULL
mRNA	NULL
species	NULL
.	NULL

Significant	NULL
levels	NULL
of	NULL
expression	NULL
were	NULL
found	NULL
only	NULL
in	NULL
B-cell	NULL
lines	NULL
and	NULL
spleen	NULL
.	NULL

Trace	NULL
amounts	NULL
of	NULL
Spi-B	NULL
mRNA	NULL
were	NULL
also	NULL
found	NULL
in	NULL
peritoneal	NULL
macrophages	NULL
and	NULL
lung	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
murine	NULL
PU.1	NULL
is	NULL
expressed	NULL
as	NULL
a	NULL
single	NULL
1.4-kb	NULL
species	NULL
at	NULL
high	NULL
levels	NULL
not	NULL
only	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
also	NULL
in	NULL
murine	NULL
myeloid	NULL
cell	NULL
lines	NULL
and	NULL
is	NULL
expressed	NULL
at	NULL
highest	NULL
levels	NULL
in	NULL
peritoneal	NULL
macrophages	NULL
.	NULL

Lower	NULL
levels	NULL
were	NULL
also	NULL
detected	NULL
in	NULL
lung	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
difficulty	NULL
with	NULL
isolation	NULL
of	NULL
intact	NULL
mRNA	NULL
from	NULL
significant	NULL
numbers	NULL
of	NULL
purified	NULL
murine	NULL
neutrophils	NULL
,	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
assess	NULL
expression	NULL
of	NULL
Spi-B	NULL
and	NULL
PU.1	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2924	NULL
CHEN	NULL
ET	NULL
AL	NULL
PU.1	NULL
protein	NULL
$	NULL
k	NULL
o	NULL
$	NULL
k	NULL
.	NULL

&	NULL
-o	NULL
4	NULL
sow	NULL
wos	NULL
£00k	NULL
%	NULL
00k	NULL
0	NULL
%	NULL
F	NULL
$	NULL
Spi-B	NULL
protein	NULL
wok	NULL
s	NULL
$	NULL
$	NULL
.	NULL

%	NULL
40	NULL
>	NULL
mos	NULL
oso	NULL
ie	NULL
£0	NULL
k	NULL
00k	NULL
0	NULL
%	NULL
*	NULL
%	NULL
U937	NULL
NE	NULL
wok	NULL
&	NULL
k	NULL
k	NULL
k	NULL
k	NULL
8	NULL
po	NULL
o	NULL
#	NULL
te	NULL
te	NULL
ot	NULL
#	NULL
tog	NULL
Competitor	NULL
-	NULL
owt	NULL
-	NULL
-	NULL
wto	NULL
-	NULL
-o	NULL
>	NULL
-	NULL
wt	NULL
m	NULL
>	NULL
-	NULL
wt	NULL
m	NULL
>	NULL
-	NULL
AM	NULL
Antibody	NULL
Fo	NULL
-	NULL
-	NULL
F	NULL
NON	NULL
-	NULL
-	NULL
-	NULL
N	NULL
-o-	NULL
-	NULL
OF	NULL
-	NULL
G	NULL
W	NULL
--	NULL
«	NULL
wlth	NULL
sin	NULL
.	NULL

wo	NULL
tuk	NULL
swage	NULL
SS	NULL
--	NULL
go	NULL
ewe	NULL
>	NULL
tang	NULL
§	NULL
--	NULL
t	NULL
%	NULL
ling	NULL
wae	NULL
|	NULL
weno	NULL
e	NULL
aol	NULL
_	NULL
s	NULL
AF	NULL
xt	NULL
«	NULL
un	NULL
.	NULL

wes	NULL
_	NULL
wat	NULL
|	NULL
F	NULL
_	NULL
--	NULL
®	NULL
1	NULL
2	NULL
%	NULL
3	NULL
4	NULL
§	NULL
6	NULL
7	NULL
$	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
1415	NULL
16	NULL
17	NULL
18	NULL
PU.1	NULL
protein	NULL
|	NULL
4	NULL
$	NULL
$	NULL
=	NULL
o=	NULL
=	NULL
=	NULL
=	NULL
>	NULL
=o	NULL
=	NULL
~	NULL
&	NULL
00	NULL
k	NULL
0k	NULL
o	NULL
>	NULL
wok	NULL
$	NULL
$	NULL
g	NULL
o	NULL
>	NULL
L937	NULL
NE	NULL
-	NULL
-	NULL
>	NULL
#	NULL
#	NULL
$	NULL
>	NULL
>	NULL
+	NULL
>	NULL
+	NULL
o=	NULL
«	NULL
ok	NULL
k	NULL
0	NULL
%	NULL
nom	NULL
ao	NULL
s	NULL
)	NULL
%	NULL
%	NULL
Neutrophil	NULL
NE	NULL
-	NULL
=-	NULL
>	NULL
-	NULL
>	NULL
0	NULL
>	NULL
=	NULL
>	NULL
+	NULL
+o	NULL
4+	NULL
4	NULL
+o	NULL
+	NULL
#	NULL
+o	NULL
+o	NULL
++	NULL
+	NULL
kok	NULL
to	NULL
+	NULL
o-Competitor	NULL
_-	NULL
PU	NULL
-	NULL
-	NULL
PU	NULL
-	NULL
-	NULL
PUMIL	NULL
Sy	NULL
Sp	NULL
-	NULL
-	NULL
PC	NULL
Mi	NULL
-	NULL
Kok	NULL
00k	NULL
0k	NULL
0k	NULL
Antibody	NULL
|	NULL
=-	NULL
==	NULL
No	NULL
-	NULL
O-	NULL
No	NULL
>	NULL
>	NULL
>	NULL
>	NULL
=-	NULL
N	NULL
£04	NULL
-	NULL
F	NULL
a	NULL
§	NULL
s	NULL
w	NULL
ox	NULL
%	NULL
:	NULL
=	NULL
were	NULL
gog	NULL
+=	NULL
»	NULL
l	NULL
SS	NULL
-	NULL
pres	NULL
tous	NULL
B	NULL
.	NULL

Fig	NULL
5	NULL
.	NULL

EMSA	NULL
(	NULL
ge	NULL
!	NULL

shift	NULL
)	NULL
analysis	NULL
of	NULL
DNA	NULL
binding	NULL
of	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Reactivity	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
and	NULL
U937	NULL
extracts	NULL
to	NULL
PU.1	NULL
antisera	NULL
is	NULL
shown	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
CD11b	NULL
promoter	NULL
PU.1	NULL
site	NULL
as	NULL
a	NULL
probe	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
legend	NULL
above	NULL
the	NULL
autoradiograph	NULL
indicates	NULL
the	NULL
source	NULL
of	NULL
protein	NULL
,	NULL
competitor	NULL
,	NULL
and	NULL
antibody	NULL
used	NULL
:	NULL
PU.1	NULL
protein	NULL
and	NULL
Spi-B	NULL
protein	NULL
,	NULL
in	NULL
vitro	NULL
translated	NULL
protein	NULL
;	NULL
U937	NULL
NE	NULL
,	NULL
U937	NULL
nuclear	NULL
extract	NULL
.	NULL

Competitors	NULL
are	NULL
the	NULL
wild-type	NULL
CD11b	NULL
oligonucleotide	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
the	NULL
CD11b	NULL
M1	NULL
mutant	NULL
(	NULL
m	NULL
)	NULL
,	NULL
which	NULL
does	NULL
not	NULL
compete	NULL
PU.1	NULL
or	NULL
Spi-B	NULL
binding	NULL
.	NULL

*	NULL
``	NULL
'	NULL
Antibodies	NULL
added	NULL
are	NULL
either	NULL
antisera	NULL
raised	NULL
against	NULL
full-length	NULL
,	NULL
bacterially	NULL
synthesized	NULL
,	NULL
PU.1	NULL
protein	NULL
(	NULL
F	NULL
)	NULL
``	NULL
;	NULL
against	NULL
an	NULL
amino	NULL
terminal	NULL
peptide	NULL
(	NULL
N	NULL
)	NULL
°	NULL
;	NULL
or	NULL
against	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
only	NULL
(	NULL
G	NULL
)	NULL
.	NULL
``	NULL

''	NULL
No	NULL
change	NULL
in	NULL
the	NULL
PU.1	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
Spi-B	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
U937	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
17	NULL
)	NULL
complexes	NULL
was	NULL
observed	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
amount	NULL
of	NULL
full-length	NULL
PU.1	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
versus	NULL
Spi-B	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
complex	NULL
correlates	NULL
with	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
observed	NULL
on	NULL
SDS	NULL
analysis	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
translated	NULL
protein	NULL
,	NULL
not	NULL
with	NULL
a	NULL
difference	NULL
in	NULL
relative	NULL
affinity	NULL
for	NULL
the	NULL
CD11b	NULL
probe	NULL
.	NULL
``	NULL

W	NULL
,	NULL
location	NULL
of	NULL
the	NULL
well	NULL
;	NULL
SS	NULL
,	NULL
supershifted	NULL
PU.1	NULL
complex	NULL
;	NULL
S	NULL
,	NULL
complex	NULL
formed	NULL
by	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
or	NULL
Spi-B	NULL
;	NULL
A*	NULL
,	NULL
cleaved	NULL
form	NULL
of	NULL
PU.1	NULL
detected	NULL
in	NULL
U937	NULL
extracts	NULL
;	NULL
and	NULL
F	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

Lanes	NULL
1	NULL
through	NULL
6	NULL
,	NULL
7	NULL
and	NULL
8	NULL
,	NULL
9	NULL
through	NULL
12	NULL
,	NULL
13	NULL
through	NULL
16	NULL
,	NULL
and	NULL
17	NULL
and	NULL
18	NULL
represent	NULL
different	NULL
experiments	NULL
performed	NULL
under	NULL
identical	NULL
conditions	NULL
.	NULL

Lane	NULL
17	NULL
is	NULL
identical	NULL
to	NULL
lanes	NULL
9	NULL
and	NULL
13	NULL
,	NULL
except	NULL
a	NULL
different	NULL
U937	NULL
extract	NULL
was	NULL
used	NULL
that	NULL
does	NULL
not	NULL
have	NULL
the	NULL
cleaved	NULL
(	NULL
A*	NULL
)	NULL
PU.1	NULL
complex	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Binding	NULL
of	NULL
neutrophil	NULL
extracts	NULL
to	NULL
the	NULL
CD11b	NULL
PU.1	NULL
site	NULL
oligonucleotide	NULL
.	NULL

EMSA	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
5A	NULL
.	NULL

Neutrophil	NULL
NE	NULL
;	NULL
human	NULL
PB	NULL
neutrophil	NULL
nuclear	NULL
extract	NULL
;	NULL
PU	NULL
,	NULL
the	NULL
wild-type	NULL
CD11b	NULL
PU.1	NULL
site	NULL
oligonucleotide	NULL
competitor	NULL
;	NULL
Sv	NULL
,	NULL
the	NULL
SV40	NULL
PU.1	NULL
site	NULL
(	NULL
both	NULL
of	NULL
which	NULL
bind	NULL
PU.1	NULL
)	NULL
°*	NULL
``	NULL
;	NULL
M1	NULL
and	NULL
Sp	NULL
,	NULL
the	NULL
CD11b	NULL
M1	NULL
PU.1	NULL
site	NULL
and	NULL
-60	NULL
CD11b	NULL
promoter	NULL
Sp1	NULL
wild-type	NULL
competitors	NULL
(	NULL
neither	NULL
of	NULL
which	NULL
bind	NULL
to	NULL
PU.1	NULL
)	NULL
``	NULL
**	NULL
;	NULL
G	NULL
antibody	NULL
,	NULL
an	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
PU.1	NULL
DNA	NULL
binding	NULL
domain	NULL
'	NULL
;	NULL
and	NULL
N	NULL
(	NULL
on	NULL
the	NULL
left	NULL
side	NULL
)	NULL
,	NULL
the	NULL
location	NULL
of	NULL
a	NULL
complex	NULL
found	NULL
in	NULL
human	NULL
neutrophils	NULL
.	NULL

Lanes	NULL
1	NULL
through	NULL
12	NULL
,	NULL
13	NULL
through	NULL
16	NULL
,	NULL
and	NULL
17	NULL
through	NULL
22	NULL
represent	NULL
different	NULL
experiments	NULL
performed	NULL
under	NULL
identical	NULL
conditions	NULL
.	NULL

In	NULL
lanes	NULL
19	NULL
and	NULL
21	NULL
,	NULL
2.8	NULL
pg	NULL
of	NULL
neutrophil	NULL
nuclear	NULL
extract	NULL
was	NULL
added	NULL
to	NULL
4	NULL
mL	NULL
of	NULL
in	NULL
vitro	NULL
translated	NULL
PU.1	NULL
protein	NULL
(	NULL
shown	NULL
in	NULL
lane	NULL
20	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
either	NULL
0°C	NULL
(	NULL
lane	NULL
19	NULL
)	NULL
or	NULL
room	NULL
temperature	NULL
(	NULL
lane	NULL
21	NULL
)	NULL
before	NULL
performing	NULL
the	NULL
EMSA	NULL
analysis	NULL
.	NULL

6070	NULL
80	NULL
9	NULL
10	NULL
1	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
21	NULL
22	NULL
r	NULL
»	NULL
»	NULL
4s	NULL
'	NULL
n	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PU.1	NULL
AND	NULL
Srpi-B	NULL
EXPRESSION	NULL
IN	NULL
MYELOID	NULL
CELLS	NULL
C	NULL
HUMAN	NULL
PU.1	NULL
s	NULL
Cess	NULL
~-\	NULL
|	NULL
\	NULL
52	NULL
%	NULL
\	NULL
i	NULL
715	NULL
%	NULL
|	NULL
HUMAN	NULL
SPI-B	NULL
{	NULL
--	NULL
-MURINE	NULL
PU.1	NULL
MURINE	NULL
SPI-B	NULL
HUMAN	NULL
PU.1	NULL
-E	NULL
,	NULL
|	NULL
‘	NULL
\	NULL
80	NULL
%	NULL
\\	NULL
i	NULL
95	NULL
%	NULL
:	NULL
MURINE	NULL
PU.1	NULL
\-MURINE	NULL
SPI-B	NULL
|	NULL
18	NULL
%	NULL
A	NULL
85	NULL
%	NULL
|	NULL
HUMAN	NULL
SPI-B	NULL
100	NULL
bp	NULL
-L	NULL
-	NULL
5	NULL
'	NULL
probe	NULL
region	NULL
-A	NULL
Sy	NULL
DNA	NULL
binding	NULL
domain	NULL
Fig	NULL
6	NULL
.	NULL

DNA	NULL
similarity	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
cDNAs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Comparison	NULL
between	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
.	NULL

Sequence	NULL
alignment	NULL
of	NULL
murine	NULL
or	NULL
human	NULL
PU.1°*	NULL
and	NULL
Spi-B	NULL
(	NULL
Gonzalez	NULL
and	NULL
Tenen	NULL
,	NULL
unpublished	NULL
sequence	NULL
,	NULL
and	NULL
Ray	NULL
et	NULL
al	NULL
'	NULL
)	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
align	NULL
program	NULL
(	NULL
DNAstar	NULL
,	NULL
Inc	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
}	NULL
.	NULL

The	NULL
5°	NULL
probe	NULL
region	NULL
portion	NULL
of	NULL
each	NULL
cDNA	NULL
was	NULL
used	NULL
in	NULL
Northern	NULL
blots	NULL
in	NULL
Figs	NULL
4B	NULL
and	NULL
7	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparison	NULL
between	NULL
human	NULL
and	NULL
murine	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
is	NULL
shown	NULL
.	NULL

Sequence	NULL
alignment	NULL
was	NULL
performed	NULL
as	NULL
for	NULL
(	NULL
A	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
when	NULL
gene-	NULL
and	NULL
species-specific	NULL
5	NULL
cDNA	NULL
probes	NULL
are	NULL
used	NULL
,	NULL
Spi-B	NULL
appears	NULL
to	NULL
be	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
only	NULL
in	NULL
certain	NULL
B-cell	NULL
lines	NULL
and	NULL
in	NULL
spleen	NULL
(	NULL
an	NULL
organ	NULL
which	NULL
contains	NULL
large	NULL
numbers	NULL
of	NULL
B	NULL
cells	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

PU.1	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
is	NULL
expressed	NULL
not	NULL
only	NULL
in	NULL
all	NULL
of	NULL
the	NULL
B-cell	NULL
lines	NULL
we	NULL
tested	NULL
,	NULL
but	NULL
also	NULL
in	NULL
all	NULL
myeloid	NULL
cell	NULL
lines	NULL
and	NULL
,	NULL
specifically	NULL
,	NULL
in	NULL
neutrophils	NULL
at	NULL
high	NULL
levels	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
related	NULL
transcription	NULL
factors	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
during	NULL
the	NULL
course	NULL
of	NULL
myeloid	NULL
development	NULL
.	NULL

PU.1	NULL
is	NULL
expressed	NULL
in	NULL
early	NULL
human	NULL
CD34*	NULL
precursors	NULL
and	NULL
upregulated	NULL
early	NULL
during	NULL
GM-CSF	NULL
induced	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
proliferation	NULL
and/or	NULL
differentiation	NULL
of	NULL
stem	NULL
cells	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
Spi-B	NULL
mRNA	NULL
was	NULL
also	NULL
initially	NULL
upregulated	NULL
and	NULL
then	NULL
downregulated	NULL
by	NULL
day	NULL
11	NULL
of	NULL
GM-CSF	NULL
culture	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
whereas	NULL
PU.1	NULL
mRNA	NULL
remains	NULL
stable	NULL
.	NULL
``	NULL

This	NULL
upregulation	NULL
of	NULL
PU.1	NULL
mRNA	NULL
is	NULL
associated	NULL
with	NULL
differentiation	NULL
of	NULL
blasts	NULL
to	NULL
a	NULL
population	NULL
that	NULL
is	NULL
mostly	NULL
promyelocytes	NULL
and	NULL
myelocytes	NULL
(	NULL
56	NULL
%	NULL
at	NULL
day	NULL
11	NULL
)	NULL
and	NULL
monocytic	NULL
cells	NULL
(	NULL
24	NULL
%	NULL
at	NULL
day	NULL
11	NULL
)	NULL
.	NULL

In	NULL
this	NULL
culture	NULL
system	NULL
,	NULL
we	NULL
2925	NULL
can	NULL
induce	NULL
myeloid	NULL
but	NULL
not	NULL
B-cell	NULL
development	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
,	NULL
were	NULL
we	NULL
able	NULL
to	NULL
induce	NULL
B-cell	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
CD34*	NULL
BM	NULL
cultures	NULL
,	NULL
we	NULL
might	NULL
see	NULL
sustained	NULL
or	NULL
increased	NULL
levels	NULL
of	NULL
Spi-B	NULL
at	NULL
later	NULL
times	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
relatively	NULL
small	NULL
numbers	NULL
of	NULL
purified	NULL
CD34	NULL
cells	NULL
in	NULL
the	NULL
BM	NULL
,	NULL
we	NULL
analyzed	NULL
PU.1	NULL
mRNA	NULL
in	NULL
these	NULL
cultures	NULL
by	NULL
RT-PCR	NULL
.	NULL

In	NULL
CD34*	NULL
cell	NULL
cultures	NULL
,	NULL
PU.1	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
most	NULL
immature	NULL
CD34*/CD38~	NULL
cells	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

When	NULL
we	NULL
investigated	NULL
expression	NULL
of	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
in	NULL
multipotential	NULL
FDCP-mix	NULL
cells	NULL
,	NULL
we	NULL
observed	NULL
significant	NULL
PU.1	NULL
mRNA	NULL
expression	NULL
only	NULL
after	NULL
induction	NULL
of	NULL
myeloid	NULL
differentiation	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
;	NULL
however	NULL
,	NULL
no	NULL
Spi-B	NULL
mRNA	NULL
expression	NULL
was	NULL
observed	NULL
.	NULL

We	NULL
also	NULL
observe	NULL
upregulation	NULL
of	NULL
PU.1	NULL
but	NULL
not	NULL
Spi-B	NULL
mRNA	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
during	NULL
G-CSF-induced	NULL
neutrophilic	NULL
differentiation	NULL
of	NULL
the	NULL
murine	NULL
progenitor	NULL
32D	NULL
line	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
PU.1	NULL
was	NULL
not	NULL
significantly	NULL
changed	NULL
during	NULL
differentiation	NULL
of	NULL
HL-60	NULL
or	NULL
U937	NULL
cells	NULL
and	NULL
suggests	NULL
that	NULL
increases	NULL
in	NULL
PU.1	NULL
expression	NULL
can	NULL
not	NULL
account	NULL
for	NULL
the	NULL
maturation	NULL
of	NULL
promyelocytic	NULL
cells	NULL
to	NULL
neutrophilic	NULL
or	NULL
monocytic	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
studies	NULL
of	NULL
the	NULL
CD11b	NULL
promoter	NULL
,	NULL
in	NULL
which	NULL
mutations	NULL
that	NULL
block	NULL
PU.1	NULL
DNA	NULL
binding	NULL
and	NULL
function	NULL
``	NULL
fail	NULL
to	NULL
block	NULL
CD11b	NULL
promoter	NULL
upregulation	NULL
during	NULL
myeloid	NULL
differentiation	NULL
(	NULL
Satterthwaite	NULL
and	NULL
Tenen	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

Because	NULL
it	NULL
is	NULL
expressed	NULL
at	NULL
highest	NULL
levels	NULL
in	NULL
mature	NULL
neutrophils	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
,	NULL
PU.1	NULL
may	NULL
be	NULL
strongly	NULL
upregulated	NULL
late	NULL
during	NULL
myeloid	NULL
maturation	NULL
(	NULL
Figs	NULL
4	NULL
and	NULL
7	NULL
)	NULL
.	NULL

The	NULL
levels	NULL
observed	NULL
in	NULL
these	NULL
mature	NULL
primary	NULL
cells	NULL
are	NULL
significantly	NULL
higher	NULL
than	NULL
those	NULL
observed	NULL
in	NULL
myeloid	NULL
cell	NULL
lines	NULL
such	NULL
as	NULL
HL-60	NULL
,	NULL
which	NULL
do	NULL
not	NULL
undergo	NULL
terminal	NULL
differentiation	NULL
characteristic	NULL
of	NULL
actual	NULL
mature	NULL
neutrophils	NULL
or	NULL
monocytes	NULL
.	NULL

``	NULL
*	NULL
In	NULL
human	NULL
cells	NULL
,	NULL
PU.1	NULL
mRNA	NULL
was	NULL
expressed	NULL
at	NULL
highest	NULL
levels	NULL
in	NULL
mature	NULL
PB	NULL
neutrophils	NULL
.	NULL

This	NULL
finding	NULL
was	NULL
consistent	NULL
with	NULL
its	NULL
lack	NULL
of	NULL
significant	NULL
downregulation	NULL
during	NULL
neutrophilic	NULL
differentiation	NULL
of	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
well	NULL
as	NULL
its	NULL
regulation	NULL
of	NULL
genes	NULL
expressed	NULL
in	NULL
neutrophils	NULL
as	NULL
well	NULL
as	NULL
macrophages	NULL
,	NULL
such	NULL
as	NULL
CD1	NULL
1b	NULL
.	NULL
``	NULL

'	NULL
Previous	NULL
investigators	NULL
also	NULL
identified	NULL
a	NULL
specific	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
neutrophils	NULL
binding	NULL
to	NULL
a	NULL
site	NULL
in	NULL
the	NULL
IL-1/3	NULL
promoter	NULL
,	NULL
``	NULL
which	NULL
recently	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
PU.1	NULL
site	NULL
.	NULL
``	NULL

We	NULL
believe	NULL
that	NULL
our	NULL
findings	NULL
are	NULL
not	NULL
inconsistent	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
,	NULL
in	NULL
which	NULL
immunohis-tochemical	NULL
studies	NULL
using	NULL
an	NULL
antiserum	NULL
directed	NULL
against	NULL
an	NULL
amino-terminal	NULL
peptide	NULL
failed	NULL
to	NULL
detect	NULL
significant	NULL
PU.1	NULL
protein	NULL
in	NULL
murine	NULL
neutrophils	NULL
.	NULL
``	NULL

In	NULL
our	NULL
gelshift	NULL
studies	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
,	NULL
we	NULL
also	NULL
failed	NULL
to	NULL
detect	NULL
full-length	NULL
PU.1	NULL
protein	NULL
capable	NULL
of	NULL
reacting	NULL
with	NULL
this	NULL
antibody	NULL
.	NULL

We	NULL
instead	NULL
detected	NULL
specific	NULL
faster	NULL
migrating	NULL
complexes	NULL
that	NULL
represent	NULL
PU.1	NULL
carboxyl-terminal	NULL
peptides	NULL
,	NULL
in	NULL
which	NULL
the	NULL
amino-terminal	NULL
domain	NULL
has	NULL
been	NULL
cleaved	NULL
and	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
retained	NULL
.	NULL

These	NULL
complexes	NULL
were	NULL
detected	NULL
because	NULL
they	NULL
react	NULL
with	NULL
specific	NULL
antisera	NULL
raised	NULL
against	NULL
either	NULL
the	NULL
entire	NULL
PU.1	NULL
protein	NULL
or	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
cleaved	NULL
form	NULL
exists	NULL
in	NULL
intact	NULL
neutrophils	NULL
and	NULL
monocytes	NULL
and	NULL
has	NULL
biologic	NULL
significance	NULL
.	NULL

However	NULL
,	NULL
we	NULL
suspect	NULL
that	NULL
PU.1	NULL
more	NULL
likely	NULL
exists	NULL
as	NULL
an	NULL
uncleaved	NULL
protein	NULL
in	NULL
the	NULL
body	NULL
and	NULL
is	NULL
cleaved	NULL
during	NULL
the	NULL
process	NULL
of	NULL
isolation	NULL
of	NULL
myeloid	NULL
cells	NULL
,	NULL
because	NULL
(	NULL
1	NULL
)	NULL
U937	NULL
extracts	NULL
rarely	NULL
do	NULL
not	NULL
have	NULL
the	NULL
cleaved	NULL
form	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lane	NULL
17	NULL
)	NULL
,	NULL
and	NULL
(	NULL
2	NULL
)	NULL
we	NULL
observe	NULL
the	NULL
faster	NULL
migrating	NULL
complex	NULL
in	NULL
myeloid	NULL
cells	NULL
(	NULL
U937	NULL
,	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2926	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
-	NULL
288	NULL
HUMAN	NULL
SPI-B	NULL
h	NULL
%	NULL
-	NULL
188	NULL
Hela	NULL
(	NULL
human	NULL
epithelial	NULL
)	NULL
--	NULL
Jurkat	NULL
(	NULL
human	NULL
T	NULL
)	NULL
--	NULL
U937	NULL
(	NULL
human	NULL
myeloid	NULL
)	NULL
___	NULL
--	NULL
-HL60	NULL
(	NULL
human	NULL
myeloid	NULL
)	NULL
--	NULL
--	NULL
-	NULL
BJA-B	NULL
(	NULL
human	NULL
pro-B	NULL
)	NULL
--	NULL
-K46	NULL
(	NULL
murine	NULL
B	NULL
)	NULL
LyD9	NULL
(	NULL
murine	NULL
pro-B	NULL
)	NULL
--	NULL
--	NULL
M	NULL
ono	NULL
Mac6	NULL
(	NULL
human	NULL
monocytic	NULL
)	NULL
,	NULL
A20	NULL
(	NULL
murine	NULL
B	NULL
)	NULL
--	NULL
-	NULL
Sp2	NULL
(	NULL
murine	NULL
myeloma	NULL
)	NULL
--	NULL
-	NULL
Macrophage	NULL
(	NULL
murine	NULL
)	NULL
-	NULL
288	NULL
HUMAN	NULL
-	NULL
188	NULL
us	NULL
-	NULL
«	NULL
anes	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
CHEN	NULL
ET	NULL
AL	NULL
B	NULL
123456	NULL
7s	NULL
MOUSE	NULL
-	NULL
288	NULL
SPL-B	NULL
-	NULL
188	NULL
A20	NULL
(	NULL
murine	NULL
B	NULL
)	NULL
Sp2	NULL
(	NULL
murine	NULL
myeloma	NULL
)	NULL
-	NULL
Macrophage	NULL
(	NULL
murine	NULL
cells	NULL
)	NULL
K46	NULL
(	NULL
murine	NULL
B	NULL
)	NULL
--	NULL
_	NULL
LyD9	NULL
(	NULL
murine	NULL
pre-B	NULL
)	NULL
--	NULL
-	NULL
--	NULL
Heart	NULL
(	NULL
murine	NULL
tissue	NULL
)	NULL
--	NULL
--	NULL
Kidney	NULL
(	NULL
murine	NULL
tissue	NULL
)	NULL
--	NULL
--	NULL
-	NULL
Liver	NULL
(	NULL
murine	NULL
tissue	NULL
)	NULL
Lung	NULL
(	NULL
murine	NULL
tissue	NULL
)	NULL
Muscle	NULL
(	NULL
murine	NULL
tissue	NULL
)	NULL
_-Spleen	NULL
(	NULL
murine	NULL
tissue	NULL
)	NULL
Raw	NULL
(	NULL
murine	NULL
monocytic	NULL
)	NULL
Brain	NULL
(	NULL
murine	NULL
tissue	NULL
)	NULL
|	NULL
#	NULL
MOUSE	NULL
S	NULL
PU.1	NULL
+	NULL
-	NULL
188	NULL
188	NULL
I	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
910111213	NULL
Fig	NULL
7	NULL
.	NULL

Relative	NULL
human	NULL
and	NULL
murine	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
mRNA	NULL
expression	NULL
using	NULL
species-	NULL
and	NULL
gene-specific	NULL
5	NULL
'	NULL
cDNA	NULL
probes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
human	NULL
probes	NULL
is	NULL
shown	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
10	NULL
g	NULL
of	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
the	NULL
cell	NULL
lines	NULL
and	NULL
tissues	NULL
indicated	NULL
.	NULL

Under	NULL
the	NULL
conditions	NULL
used	NULL
,	NULL
we	NULL
do	NULL
not	NULL
detect	NULL
cross-reaction	NULL
between	NULL
human	NULL
and	NULL
murine	NULL
probes	NULL
or	NULL
between	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
(	NULL
see	NULL
Results	NULL
)	NULL
.	NULL

The	NULL
arrows	NULL
at	NULL
the	NULL
left	NULL
of	NULL
the	NULL
top	NULL
panel	NULL
indicate	NULL
the	NULL
rare	NULL
5-kb	NULL
(	NULL
--	NULL
-	NULL
)	NULL
,	NULL
the	NULL
rarer	NULL
3-kb	NULL
(	NULL
+	NULL
>	NULL
>	NULL
>	NULL
)	NULL
,	NULL
and	NULL
the	NULL
abundant	NULL
1.4-kb	NULL
(	NULL
~	NULL
)	NULL
human	NULL
Spi-B	NULL
mRNA	NULL
species	NULL
.	NULL

The	NULL
arrows	NULL
at	NULL
the	NULL
left	NULL
of	NULL
the	NULL
middle	NULL
panel	NULL
indicate	NULL
the	NULL
1.4-kb	NULL
human	NULL
PU.1	NULL
mRNA	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
for	NULL
4	NULL
days	NULL
for	NULL
human	NULL
Spi-B	NULL
and	NULL
for	NULL
22	NULL
hours	NULL
for	NULL
human	NULL
PU.1	NULL
.	NULL

The	NULL
panel	NULL
at	NULL
the	NULL
bottom	NULL
shows	NULL
the	NULL
18S	NULL
oligonucleotide	NULL
hybridization	NULL
as	NULL
a	NULL
control	NULL
for	NULL
loading	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
murine	NULL
probes	NULL
is	NULL
shown	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
(	NULL
A	NULL
)	NULL
using	NULL
10	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
isolated	NULL
from	NULL
the	NULL
cell	NULL
lines	NULL
and	NULL
tissues	NULL
indicated	NULL
.	NULL

The	NULL
arrows	NULL
at	NULL
the	NULL
left	NULL
of	NULL
the	NULL
top	NULL
panel	NULL
indicate	NULL
the	NULL
3-kb	NULL
murine	NULL
Spi-B	NULL
mRNA	NULL
species	NULL
.	NULL

The	NULL
arrow	NULL
at	NULL
the	NULL
left	NULL
of	NULL
the	NULL
middle	NULL
panel	NULL
indicates	NULL
1.4-kb	NULL
murine	NULL
Spi-B	NULL
mRNA	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
for	NULL
4	NULL
days	NULL
for	NULL
murine	NULL
Spi-B	NULL
and	NULL
for	NULL
3	NULL
days	NULL
for	NULL
murine	NULL
PU.1	NULL
.	NULL

The	NULL
panel	NULL
at	NULL
the	NULL
bottom	NULL
shows	NULL
the	NULL
18S	NULL
oligonucleotide	NULL
hybridization	NULL
as	NULL
a	NULL
control	NULL
for	NULL
loading	NULL
.	NULL

A	NULL
faint	NULL
3-kb	NULL
mRNA	NULL
signal	NULL
is	NULL
detected	NULL
in	NULL
the	NULL
upper	NULL
panel	NULL
in	NULL
lanes	NULL
5	NULL
and	NULL
9	NULL
.	NULL

HL-60	NULL
,	NULL
neutrophils	NULL
;	NULL
which	NULL
contain	NULL
significant	NULL
levels	NULL
of	NULL
prote-ases	NULL
)	NULL
and	NULL
not	NULL
,	NULL
as	NULL
a	NULL
rule	NULL
,	NULL
in	NULL
B-cell	NULL
extracts	NULL
,	NULL
``	NULL
a	NULL
finding	NULL
which	NULL
has	NULL
been	NULL
observed	NULL
by	NULL
other	NULL
laboratories	NULL
as	NULL
well	NULL
.	NULL
``	NULL

Further	NULL
support	NULL
for	NULL
the	NULL
idea	NULL
that	NULL
PU.1	NULL
is	NULL
cleaved	NULL
by	NULL
a	NULL
proteinase	NULL
during	NULL
extraction	NULL
comes	NULL
from	NULL
our	NULL
experiment	NULL
in	NULL
which	NULL
addition	NULL
of	NULL
neutrophil	NULL
nuclear	NULL
extracts	NULL
to	NULL
in	NULL
vitro	NULL
translated	NULL
PU	NULL
.	NULL

1	NULL
protein	NULL
induces	NULL
the	NULL
loss	NULL
of	NULL
full-length	NULL
PU.1	NULL
complex	NULL
S	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
new	NULL
faster	NULL
migrating	NULL
complex	NULL
that	NULL
migrates	NULL
with	NULL
a	NULL
mobility	NULL
identical	NULL
to	NULL
the	NULL
complex	NULL
N	NULL
found	NULL
in	NULL
human	NULL
neutrophils	NULL
(	NULL
Fig	NULL
5B	NULL
,	NULL
lanes	NULL
19	NULL
and	NULL
21	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
trypsin	NULL
to	NULL
U937	NULL
extracts	NULL
also	NULL
induces	NULL
the	NULL
loss	NULL
of	NULL
full-length	NULL
PU.1	NULL
complex	NULL
S	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
complex	NULL
with	NULL
a	NULL
mobility	NULL
very	NULL
similar	NULL
to	NULL
the	NULL
complex	NULL
N	NULL
found	NULL
in	NULL
human	NULL
neutrophils	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Of	NULL
interest	NULL
is	NULL
that	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
smaller	NULL
complex	NULL
in	NULL
U937	NULL
extracts	NULL
is	NULL
significantly	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
the	NULL
intact	NULL
protein	NULL
.	NULL

Other	NULL
investigators	NULL
have	NULL
previously	NULL
described	NULL
an	NULL
inhibitory	NULL
domain	NULL
in	NULL
ets-1	NULL
,	NULL
in	NULL
which	NULL
deletion	NULL
of	NULL
the	NULL
domain	NULL
led	NULL
to	NULL
a	NULL
similar	NULL
increase	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
faster	NULL
migrating	NULL
complexes	NULL
.	NULL
``	NULL

''	NULL
``	NULL
In	NULL
one	NULL
of	NULL
these	NULL
studies	NULL
,	NULL
deletion	NULL
of	NULL
similar	NULL
regions	NULL
of	NULL
the	NULL
PU.1	NULL
protein	NULL
did	NULL
not	NULL
augment	NULL
DNA	NULL
binding	NULL
.	NULL
``	NULL

Our	NULL
studies	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
suggest	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
inhibitory	NULL
domain	NULL
in	NULL
PU.1	NULL
located	NULL
in	NULL
a	NULL
distinct	NULL
site	NULL
not	NULL
previously	NULL
investigated	NULL
by	NULL
this	NULL
group	NULL
.	NULL

Further	NULL
mapping	NULL
of	NULL
the	NULL
cleavage	NULL
site	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
show	NULL
directly	NULL
the	NULL
presence	NULL
of	NULL
such	NULL
an	NULL
inhibitory	NULL
region	NULL
.	NULL

Our	NULL
most	NULL
significant	NULL
finding	NULL
is	NULL
that	NULL
the	NULL
closely	NULL
related	NULL
transcription	NULL
factor	NULL
Spi-B	NULL
is	NULL
not	NULL
expressed	NULL
at	NULL
significant	NULL
lev-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

PU.1	NULL
AND	NULL
Spi-B	NULL
EXPRESSION	NULL
IN	NULL
MYELOID	NULL
CELLS	NULL
els	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Using	NULL
highly	NULL
species-	NULL
and	NULL
gene-specific	NULL
5	NULL
'	NULL
cDNA	NULL
probes	NULL
,	NULL
we	NULL
can	NULL
distinguish	NULL
between	NULL
human	NULL
and	NULL
murine	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
on	NULL
Northern	NULL
blots	NULL
and	NULL
fail	NULL
to	NULL
detect	NULL
significant	NULL
amounts	NULL
of	NULL
Spi-B	NULL
mRNA	NULL
in	NULL
murine	NULL
or	NULL
human	NULL
myeloid	NULL
lines	NULL
or	NULL
cells	NULL
(	NULL
Figs	NULL
4	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
distinct	NULL
patterns	NULL
of	NULL
expression	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
,	NULL
although	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
PU.1	NULL
promoters	NULL
are	NULL
highly	NULL
conserved	NULL
(	NULL
with	NULL
90	NULL
%	NULL
similarity	NULL
in	NULL
the	NULL
proximal	NULL
promoter	NULL
regions	NULL
and	NULL
100	NULL
%	NULL
identity	NULL
in	NULL
a	NULL
100-bp	NULL
region	NULL
encompassing	NULL
the	NULL
tran-scriptional	NULL
start	NULL
site	NULL
)	NULL
,	NULL
we	NULL
can	NULL
detect	NULL
no	NULL
similarity	NULL
between	NULL
the	NULL
murine	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
promoters	NULL
(	NULL
Gonzalez	NULL
et	NULL
al	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
Spi-B	NULL
shares	NULL
DNA	NULL
binding	NULL
specificity	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
PU.1	NULL
for	NULL
a	NULL
number	NULL
of	NULL
myeloid	NULL
promoters	NULL
,	NULL
including	NULL
CD11b*	NULL
and	NULL
the	NULL
M-CSFR	NULL
.	NULL
``	NULL

At	NULL
levels	NULL
similar	NULL
to	NULL
the	NULL
transactivation	NULL
observed	NULL
with	NULL
PU.1	NULL
,	NULL
``	NULL
Spi-B	NULL
can	NULL
transactivate	NULL
the	NULL
M-CSFR	NULL
promoter	NULL
fivefold	NULL
and	NULL
the	NULL
CD11b	NULL
promoter	NULL
twofold	NULL
in	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
express	NULL
PU.1	NULL
or	NULL
Spi-B	NULL
(	NULL
Burn	NULL
and	NULL
Tenen	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
may	NULL
have	NULL
at	NULL
least	NULL
some	NULL
redundancy	NULL
in	NULL
function	NULL
in	NULL
vitro	NULL
but	NULL
clearly	NULL
have	NULL
very	NULL
different	NULL
patterns	NULL
of	NULL
expression	NULL
in	NULL
vivo	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
are	NULL
likely	NULL
to	NULL
play	NULL
different	NULL
roles	NULL
in	NULL
hematopoietic	NULL
development	NULL
and	NULL
differentiation	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
think	NULL
it	NULL
unlikely	NULL
that	NULL
Spi-B	NULL
will	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
myeloid	NULL
gene	NULL
expression	NULL
,	NULL
but	NULL
its	NULL
roles	NULL
in	NULL
early	NULL
hematopoiesis	NULL
and	NULL
B-cell	NULL
development	NULL
are	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
Drs	NULL
E.	NULL
Spooncer	NULL
for	NULL
providing	NULL
the	NULL
FDCP-mix	NULL
A4	NULL
cell	NULL
line	NULL
,	NULL
C.	NULL
Terhorst	NULL
for	NULL
BJA-B	NULL
and	NULL
K46	NULL
,	NULL
and	NULL
H.W.L	NULL
.	NULL

Ziegler-Heitbrock	NULL
for	NULL
the	NULL
Mono	NULL
Mac	NULL
6	NULL
cell	NULL
line	NULL
;	NULL
Drs	NULL
R.	NULL
Maki	NULL
and	NULL
D.	NULL
Galson	NULL
for	NULL
providing	NULL
murine	NULL
PU.1	NULL
cDNAs	NULL
and	NULL
F.	NULL
Moreau-Gachelin	NULL
for	NULL
providing	NULL
human	NULL
PU.1	NULL
and	NULL
Spi-B	NULL
cDNA	NULL
clones	NULL
;	NULL
Drs	NULL
R.	NULL
Maki	NULL
and	NULL
D.	NULL
Kabat	NULL
for	NULL
PU.1	NULL
antisera	NULL
;	NULL
Drs	NULL
S.	NULL
Ackerman	NULL
for	NULL
assistance	NULL
with	NULL
neutrophil	NULL
purification	NULL
and	NULL
M.	NULL
Petrovick	NULL
for	NULL
assistance	NULL
with	NULL
analysis	NULL
of	NULL
PU.1	NULL
expression	NULL
in	NULL
neutrophils	NULL
;	NULL
Drs	NULL
S.	NULL
Dziennis	NULL
for	NULL
assistance	NULL
with	NULL
isolation	NULL
of	NULL
murine	NULL
tissues	NULL
;	NULL
and	NULL
J.	NULL
Griffin	NULL
for	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
and	NULL
for	NULL
assisting	NULL
in	NULL
CD34*/CD38~	NULL
cell	NULL
purification	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
T.	NULL
Burn	NULL
and	NULL
A.	NULL
Satterthwaite	NULL
for	NULL
many	NULL
helpful	NULL
discussions	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Moreau-Gachelin	NULL
F	NULL
,	NULL
Tavitian	NULL
A	NULL
,	NULL
Tambourin	NULL
P	NULL
:	NULL
Spi-1	NULL
is	NULL
a	NULL
putative	NULL
oncogene	NULL
in	NULL
virally	NULL
induced	NULL
murine	NULL
erythroleukaemias	NULL
.	NULL

Nature	NULL
331:277	NULL
,	NULL
1988	NULL
2	NULL
.	NULL

Paul	NULL
R	NULL
,	NULL
Schuetze	NULL
S	NULL
,	NULL
Kozak	NULL
SL	NULL
,	NULL
Kozak	NULL
CA	NULL
,	NULL
Kabat	NULL
D	NULL
:	NULL
The	NULL
Sfpi-1	NULL
proviral	NULL
integration	NULL
site	NULL
of	NULL
Friend	NULL
erythroleukemia	NULL
encodes	NULL
the	NULL
ets-related	NULL
transcription	NULL
factor	NULL
Pu.1	NULL
.	NULL

J	NULL
Virol	NULL
65:464	NULL
,	NULL
1991	NULL
3	NULL
.	NULL

Klemsz	NULL
MJ	NULL
,	NULL
McKercher	NULL
SR	NULL
,	NULL
Celada	NULL
A	NULL
,	NULL
Van	NULL
Beveren	NULL
C	NULL
,	NULL
Maki	NULL
RA	NULL
:	NULL
The	NULL
macrophage	NULL
and	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
PU.1	NULL
is	NULL
related	NULL
to	NULL
the	NULL
ets	NULL
oncogene	NULL
.	NULL

Cell	NULL
61:113	NULL
,	NULL
1990	NULL
4	NULL
.	NULL

Voso	NULL
MT	NULL
,	NULL
Burn	NULL
TC	NULL
,	NULL
Wulf	NULL
G	NULL
,	NULL
Lim	NULL
B	NULL
,	NULL
Leone	NULL
G	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Inhibition	NULL
of	NULL
hematopoiesis	NULL
by	NULL
competitive	NULL
binding	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
PU.1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:7932	NULL
,	NULL
1994	NULL
5	NULL
.	NULL

Schuetze	NULL
S	NULL
,	NULL
Paul	NULL
R	NULL
,	NULL
Gliniak	NULL
BC	NULL
,	NULL
Kabat	NULL
D	NULL
:	NULL
Role	NULL
of	NULL
the	NULL
PU.1	NULL
transcription	NULL
factor	NULL
in	NULL
controlling	NULL
differentiation	NULL
of	NULL
Friend	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:2967	NULL
,	NULL
1992	NULL
6	NULL
.	NULL

Schuetze	NULL
S	NULL
,	NULL
Stenberg	NULL
PE	NULL
,	NULL
Kabat	NULL
D	NULL
:	NULL
The	NULL
Ets-related	NULL
transcription	NULL
factor	NULL
PU.1	NULL
immortalizes	NULL
erythroblasts	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:5670	NULL
,	NULL
1993	NULL
7	NULL
.	NULL

Ray	NULL
D	NULL
,	NULL
Bosselut	NULL
R	NULL
,	NULL
Ghysdael	NULL
J	NULL
,	NULL
Mattei	NULL
MG	NULL
,	NULL
Tavitian	NULL
A	NULL
,	NULL
Moreau-Gachelin	NULL
F	NULL
:	NULL
Characterization	NULL
of	NULL
Spi-B	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
related	NULL
to	NULL
the	NULL
putative	NULL
oncoprotein	NULL
Spi-1/PU.1	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:4297	NULL
,	NULL
1992	NULL
2927	NULL
8	NULL
.	NULL

Ray	NULL
D	NULL
,	NULL
Culine	NULL
S	NULL
,	NULL
Tavitain	NULL
A	NULL
,	NULL
Moreau-Gachelin	NULL
F	NULL
:	NULL
The	NULL
human	NULL
homologue	NULL
of	NULL
the	NULL
putative	NULL
proto-oncogene	NULL
Spi-1	NULL
:	NULL
Characterization	NULL
and	NULL
expression	NULL
in	NULL
tumors	NULL
.	NULL

Oncogene	NULL
5:663	NULL
,	NULL
1990	NULL
9	NULL
.	NULL

Karim	NULL
FD	NULL
,	NULL
Umess	NULL
LD	NULL
,	NULL
Thummel	NULL
CS	NULL
,	NULL
Klemsz	NULL
MJ	NULL
,	NULL
McKercher	NULL
SR	NULL
,	NULL
Celada	NULL
A	NULL
,	NULL
Van	NULL
Beveren	NULL
C	NULL
,	NULL
Maki	NULL
RA	NULL
,	NULL
Gunther	NULL
CV	NULL
,	NULL
Nye	NULL
JA	NULL
,	NULL
Graves	NULL
BJ	NULL
:	NULL
The	NULL
ETS-domain	NULL
:	NULL
A	NULL
new	NULL
DNA-binding	NULL
motif	NULL
that	NULL
recognizes	NULL
a	NULL
purine-rich	NULL
core	NULL
DNA	NULL
sequence	NULL
.	NULL

Genes	NULL
Dev	NULL
4:1451	NULL
,	NULL
1990	NULL
10	NULL
.	NULL

Wasylyk	NULL
B	NULL
,	NULL
Hahn	NULL
SL	NULL
,	NULL
Giovane	NULL
A	NULL
:	NULL
The	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Eur	NULL
J	NULL
Biochem	NULL
211:7	NULL
,	NULL
1993	NULL
11	NULL
.	NULL

Pahl	NULL
HL	NULL
,	NULL
Scheibe	NULL
RJ	NULL
,	NULL
Zhang	NULL
DE	NULL
,	NULL
Chen	NULL
HM	NULL
,	NULL
Galson	NULL
DL	NULL
,	NULL
Maki	NULL
RA	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
The	NULL
proto-oncogene	NULL
PU.1	NULL
regulates	NULL
expression	NULL
of	NULL
the	NULL
myeloid-specific	NULL
CD11b	NULL
promoter	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:5014	NULL
,	NULL
1993	NULL
12	NULL
.	NULL

Zhang	NULL
DE	NULL
,	NULL
Hetherington	NULL
CJ	NULL
,	NULL
Chen	NULL
HM	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
The	NULL
macrophage	NULL
transcription	NULL
factor	NULL
PU.1	NULL
directs	NULL
tissue	NULL
specific	NULL
expression	NULL
of	NULL
the	NULL
macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
receptor	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:373	NULL
,	NULL
1994	NULL
13	NULL
.	NULL

Moulton	NULL
KS	NULL
,	NULL
Semple	NULL
K	NULL
,	NULL
Wu	NULL
H	NULL
,	NULL
Glass	NULL
CK	NULL
:	NULL
Cell-specific	NULL
expression	NULL
of	NULL
the	NULL
macrophage	NULL
scavenger	NULL
receptor	NULL
gene	NULL
is	NULL
dependent	NULL
on	NULL
PU.1	NULL
and	NULL
a	NULL
composite	NULL
AP-l/ets	NULL
motif	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:4408	NULL
,	NULL
1994	NULL
14	NULL
.	NULL

Shin	NULL
MK	NULL
,	NULL
Koshland	NULL
ME	NULL
:	NULL
Ets-related	NULL
protein	NULL
PU.1	NULL
regulates	NULL
expression	NULL
of	NULL
the	NULL
immunoglobulin	NULL
J-chain	NULL
gene	NULL
through	NULL
a	NULL
novel	NULL
Ets-binding	NULL
element	NULL
.	NULL

Genes	NULL
Dev	NULL
7:2006	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Eisenbeis	NULL
CF	NULL
,	NULL
Singh	NULL
H	NULL
,	NULL
Storb	NULL
U	NULL
:	NULL
PU.1	NULL
is	NULL
a	NULL
component	NULL
of	NULL
a	NULL
multiprotein	NULL
complex	NULL
which	NULL
binds	NULL
an	NULL
essential	NULL
site	NULL
in	NULL
the	NULL
murine	NULL
immunoglobulin	NULL
lambda-2-4	NULL
enhancer	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:6452	NULL
,	NULL
1993	NULL
16	NULL
.	NULL

Pongubala	NULL
JM	NULL
,	NULL
Nagulapalli	NULL
S	NULL
,	NULL
Klemsz	NULL
MJ	NULL
,	NULL
McKercher	NULL
SR	NULL
,	NULL
Maki	NULL
RA	NULL
,	NULL
Atchison	NULL
ML	NULL
:	NULL
PU.1	NULL
recruits	NULL
a	NULL
second	NULL
nuclear	NULL
factor	NULL
to	NULL
a	NULL
site	NULL
important	NULL
for	NULL
immunoglobulin	NULL
kappa	NULL
3	NULL
``	NULL
enhancer	NULL
activity	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:368	NULL
,	NULL
1992	NULL
17	NULL
.	NULL

Galson	NULL
DL	NULL
,	NULL
Hensold	NULL
JO	NULL
,	NULL
Bishop	NULL
TR	NULL
,	NULL
Schalling	NULL
M	NULL
,	NULL
Dandrea	NULL
AD	NULL
,	NULL
Jones	NULL
C	NULL
,	NULL
Auron	NULL
PE	NULL
,	NULL
Housman	NULL
DE	NULL
:	NULL
Mouse	NULL
beta-globin	NULL
DNA-binding	NULL
protein	NULL
B1	NULL
is	NULL
identical	NULL
to	NULL
a	NULL
proto-oncogene	NULL
,	NULL
the	NULL
transcription	NULL
factor	NULL
Spi-1/PU.1	NULL
,	NULL
and	NULL
is	NULL
restricted	NULL
in	NULL
expression	NULL
to	NULL
hematopoietic	NULL
cells	NULL
and	NULL
the	NULL
testis	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:2929	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

Hromas	NULL
R	NULL
,	NULL
Orazi	NULL
A	NULL
,	NULL
Neiman	NULL
RS	NULL
,	NULL
Maki	NULL
R	NULL
,	NULL
Vanbeveran	NULL
C	NULL
,	NULL
Moore	NULL
J	NULL
,	NULL
Klemsz	NULL
M	NULL
:	NULL
Hematopoietic	NULL
lineage-restricted	NULL
and	NULL
stage-restricted	NULL
expression	NULL
of	NULL
the	NULL
ETS	NULL
oncogene	NULL
family	NULL
member	NULL
PU.1	NULL
.	NULL

Blood	NULL
82:2998	NULL
,	NULL
1993	NULL
19	NULL
.	NULL

Pevny	NULL
L	NULL
,	NULL
Simon	NULL
MC	NULL
,	NULL
Robertson	NULL
E	NULL
,	NULL
Klein	NULL
WH	NULL
,	NULL
Tsai	NULL
SF	NULL
,	NULL
D'Agati	NULL
V	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Costantini	NULL
F	NULL
:	NULL
Erythroid	NULL
differentiation	NULL
in	NULL
chi-maeric	NULL
mice	NULL
blocked	NULL
by	NULL
a	NULL
targeted	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
for	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Nature	NULL
349:257	NULL
,	NULL
1991	NULL
20	NULL
.	NULL

Gabbianelli	NULL
M	NULL
,	NULL
Sargiacomo	NULL
M	NULL
,	NULL
Pelosi	NULL
E	NULL
,	NULL
Testa	NULL
U	NULL
,	NULL
Isacchi	NULL
G	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
``	NULL
'Pure	NULL
``	NULL
human	NULL
hematopoietic	NULL
progenitors	NULL
:	NULL
Permissive	NULL
action	NULL
of	NULL
basic	NULL
fibroblast	NULL
growth	NULL
factor	NULL
.	NULL

Science	NULL
249:1561	NULL
,	NULL
1990	NULL
21	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
22	NULL
.	NULL

Amaout	NULL
MA	NULL
,	NULL
Gupta	NULL
SK	NULL
,	NULL
Pierce	NULL
MW	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
alpha	NULL
subunit	NULL
of	NULL
human	NULL
leukocyte	NULL
adhesion	NULL
receptor	NULL
Mol	NULL
(	NULL
complement	NULL
receptor	NULL
type	NULL
3	NULL
)	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
106:2153	NULL
,	NULL
1988	NULL
23	NULL
.	NULL

Arcari	NULL
P	NULL
,	NULL
Martinelli	NULL
R	NULL
,	NULL
Salvatore	NULL
F	NULL
:	NULL
The	NULL
complete	NULL
sequence	NULL
of	NULL
a	NULL
full	NULL
length	NULL
cDNA	NULL
for	NULL
human	NULL
liver	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
:	NULL
Evidence	NULL
for	NULL
multiple	NULL
mRNA	NULL
species	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
12:9179	NULL
,	NULL
1984	NULL
24	NULL
.	NULL

Feinberg	NULL
AP	NULL
,	NULL
Vogelstein	NULL
B	NULL
:	NULL
A	NULL
technique	NULL
for	NULL
radiolabeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
Biochem	NULL
132:6	NULL
,	NULL
1983	NULL
25	NULL
.	NULL

Rosenberg	NULL
HF	NULL
,	NULL
Ackerman	NULL
SJ	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
An	NULL
alternative	NULL
method	NULL
for	NULL
labeling	NULL
oligonucleotide	NULL
probes	NULL
for	NULL
screening	NULL
cDNA	NULL
li-braries	NULL
.	NULL

Biotechniques	NULL
8:384	NULL
,	NULL
1990	NULL
26	NULL
.	NULL

Klein	NULL
G	NULL
,	NULL
Lindahl	NULL
T	NULL
,	NULL
Jondal	NULL
M	NULL
,	NULL
Leibold	NULL
W	NULL
,	NULL
Menezes	NULL
J	NULL
,	NULL
Nilsson	NULL
K	NULL
,	NULL
Sundstrom	NULL
C	NULL
:	NULL
Continuous	NULL
lymphoid	NULL
cell	NULL
lines	NULL
with	NULL
characteristics	NULL
of	NULL
B	NULL
cells	NULL
(	NULL
bone-marrow-derived	NULL
)	NULL
,	NULL
lacking	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2928	NULL
genome	NULL
and	NULL
derived	NULL
from	NULL
three	NULL
human	NULL
lymphomas	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sei	NULL
USA	NULL
71:3283	NULL
,	NULL
1974	NULL
27	NULL
.	NULL

Ziegler-Heitbrock	NULL
HW	NULL
,	NULL
Thiel	NULL
E	NULL
,	NULL
Futterer	NULL
A	NULL
,	NULL
Herzog	NULL
V	NULL
,	NULL
Wirtz	NULL
A	NULL
,	NULL
Riethmuller	NULL
G	NULL
:	NULL
Establishment	NULL
of	NULL
a	NULL
human	NULL
cell	NULL
line	NULL
(	NULL
Mono	NULL
Mac	NULL
6	NULL
)	NULL
with	NULL
characteristics	NULL
of	NULL
mature	NULL
monocytes	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
41:456	NULL
,	NULL
1988	NULL
28	NULL
.	NULL

Palacios	NULL
R	NULL
,	NULL
Karasuyama	NULL
H	NULL
,	NULL
Rolink	NULL
A	NULL
:	NULL
Ly1*	NULL
PRO-B	NULL
lympho-cyte	NULL
clones	NULL
.	NULL

Phenotype	NULL
,	NULL
growth	NULL
requirements	NULL
and	NULL
differentiation	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

EMBO	NULL
J	NULL
6:3687	NULL
,	NULL
1987	NULL
29	NULL
.	NULL

Spooncer	NULL
E	NULL
,	NULL
Heyworth	NULL
CM	NULL
,	NULL
Dunn	NULL
A	NULL
,	NULL
Dexter	NULL
TM	NULL
:	NULL
Self-re-newal	NULL
and	NULL
differentiation	NULL
of	NULL
interleukin-3-dependent	NULL
multipotent	NULL
stem	NULL
cells	NULL
are	NULL
modulated	NULL
by	NULL
stromal	NULL
cells	NULL
and	NULL
serum	NULL
factors	NULL
.	NULL

Differentiation	NULL
31:111	NULL
,	NULL
1986	NULL
30	NULL
.	NULL

Chirgwin	NULL
JM	NULL
,	NULL
Przybyla	NULL
AE	NULL
,	NULL
MacDonald	NULL
RJ	NULL
,	NULL
Rutter	NULL
WJ	NULL
:	NULL
Isolation	NULL
of	NULL
biologically	NULL
active	NULL
ribonucleic	NULL
acid	NULL
from	NULL
sources	NULL
rich	NULL
in	NULL
ribonuclease	NULL
.	NULL

Biochemistry	NULL
18:5294	NULL
,	NULL
1979	NULL
31	NULL
.	NULL

Torezynski	NULL
RM	NULL
,	NULL
Fuke	NULL
M	NULL
,	NULL
Bollon	NULL
AP	NULL
:	NULL
Cloning	NULL
and	NULL
sequencing	NULL
of	NULL
a	NULL
human	NULL
18	NULL
$	NULL
ribosomal	NULL
RNA	NULL
gene	NULL
.	NULL

DNA	NULL
4:283	NULL
,	NULL
1985	NULL
32	NULL
.	NULL

Barbu	NULL
V	NULL
,	NULL
Dautry	NULL
F	NULL
:	NULL
Northern	NULL
blot	NULL
normalization	NULL
with	NULL
a	NULL
28S	NULL
rRNA	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:7115	NULL
,	NULL
1989	NULL
33	NULL
.	NULL

Dignam	NULL
JD	NULL
,	NULL
Lebovitz	NULL
RM	NULL
,	NULL
Roeder	NULL
RG	NULL
:	NULL
Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
11:1475	NULL
,	NULL
1983	NULL
34	NULL
.	NULL

Zhang	NULL
DE	NULL
,	NULL
Hoyt	NULL
PR	NULL
,	NULL
Papaconstantinou	NULL
J	NULL
:	NULL
Localization	NULL
of	NULL
DNA	NULL
protein-binding	NULL
sites	NULL
in	NULL
the	NULL
proximal	NULL
and	NULL
distal	NULL
promoter	NULL
regions	NULL
of	NULL
the	NULL
mouse	NULL
alpha-fetoprotein	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
265:3382	NULL
,	NULL
1990	NULL
35	NULL
.	NULL

Pahl	NULL
HL	NULL
,	NULL
Rosmarin	NULL
AG	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
myeloid	NULL
specific	NULL
CD11b	NULL
promoter	NULL
.	NULL

Blood	NULL
79:865	NULL
,	NULL
1992	NULL
36	NULL
.	NULL

Civin	NULL
CI	NULL
,	NULL
Strauss	NULL
LC	NULL
,	NULL
Brovall	NULL
C	NULL
,	NULL
Fackler	NULL
MJ	NULL
,	NULL
Schwartz	NULL
JF	NULL
,	NULL
Shaper	NULL
JH	NULL
:	NULL
Antigenic	NULL
analysis	NULL
of	NULL
hematopoiesis	NULL
.	NULL

III	NULL
.	NULL

A	NULL
hematopoietic	NULL
progenitor	NULL
cell	NULL
surface	NULL
antigen	NULL
defined	NULL
by	NULL
a	NULL
monoclonal	NULL
antibody	NULL
raised	NULL
against	NULL
KG-1a	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
133:157	NULL
,	NULL
1984	NULL
37	NULL
.	NULL

Mouthon	NULL
MA	NULL
,	NULL
Bernard	NULL
O	NULL
,	NULL
Mitjavila	NULL
MT	NULL
,	NULL
Romeo	NULL
PH	NULL
,	NULL
Vain-chenker	NULL
W	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
Expression	NULL
of	NULL
tal-1	NULL
and	NULL
GATA-bind-ing	NULL
proteins	NULL
during	NULL
human	NULL
hematopoiesis	NULL
.	NULL

Blood	NULL
81:647	NULL
,	NULL
1993	NULL
38	NULL
.	NULL

Collins	NULL
SJ	NULL
:	NULL
The	NULL
HL-60	NULL
promyelocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
:	NULL
Pro-liferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
cellular	NULL
oncogene	NULL
expression	NULL
.	NULL

Blood	NULL
70:1233	NULL
.	NULL

1987	NULL
CHEN	NULL
ET	NULL
AL	NULL
39	NULL
.	NULL

Oberg	NULL
F	NULL
,	NULL
Botling	NULL
J	NULL
,	NULL
Nilsson	NULL
K	NULL
:	NULL
Functional	NULL
antagonism	NULL
between	NULL
vitamin-D	NULL
(	NULL
3	NULL
)	NULL
and	NULL
retinoic	NULL
acid	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CD14	NULL
and	NULL
CD23	NULL
expression	NULL
during	NULL
monocytic	NULL
differentiation	NULL
of	NULL
U-937	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
150:3487	NULL
,	NULL
1993	NULL
40	NULL
.	NULL

Hickstein	NULL
DD	NULL
,	NULL
Back	NULL
AL	NULL
,	NULL
Collins	NULL
SJ	NULL
:	NULL
Regulation	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
CD1	NULL
1b	NULL
and	NULL
CD18	NULL
subunits	NULL
of	NULL
the	NULL
neutrophil	NULL
adherence	NULL
receptor	NULL
during	NULL
human	NULL
myeloid	NULL
differentiation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
264:21812	NULL
,	NULL
1989	NULL
41	NULL
.	NULL

Todd	NULL
RF	NULL
,	NULL
Nadler	NULL
LM	NULL
,	NULL
Schlossman	NULL
SF	NULL
:	NULL
Antigens	NULL
on	NULL
human	NULL
monocytes	NULL
identified	NULL
by	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

J	NULL
Immunol	NULL
126:1435	NULL
,	NULL
1981	NULL
42	NULL
.	NULL

Griffin	NULL
JD	NULL
,	NULL
Ritz	NULL
J	NULL
,	NULL
Nadler	NULL
LM	NULL
,	NULL
Schlossman	NULL
SF	NULL
:	NULL
Expression	NULL
of	NULL
myeloid	NULL
differentiation	NULL
antigens	NULL
on	NULL
normal	NULL
and	NULL
malignant	NULL
myeloid	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
68:932	NULL
,	NULL
1981	NULL
43	NULL
.	NULL

Hunninghake	NULL
GW	NULL
,	NULL
Monks	NULL
BG	NULL
,	NULL
Geist	NULL
LJ	NULL
,	NULL
Monick	NULL
MM	NULL
,	NULL
Mon-roy	NULL
MA	NULL
,	NULL
Stinski	NULL
MF	NULL
,	NULL
Webb	NULL
AC	NULL
,	NULL
Dayer	NULL
JM	NULL
,	NULL
Auron	NULL
PE	NULL
,	NULL
Fenton	NULL
MJ	NULL
:	NULL
The	NULL
functional	NULL
importance	NULL
of	NULL
a	NULL
cap	NULL
site-proximal	NULL
region	NULL
of	NULL
the	NULL
human	NULL
prointerleukin	NULL
1	NULL
beta	NULL
gene	NULL
is	NULL
defined	NULL
by	NULL
viral	NULL
protein	NULL
trans-activation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:3439	NULL
,	NULL
1992	NULL
44	NULL
.	NULL

Kominato	NULL
Y	NULL
,	NULL
Galson	NULL
DL	NULL
,	NULL
Waterman	NULL
WR	NULL
,	NULL
Webb	NULL
AC	NULL
,	NULL
Auron	NULL
PE	NULL
:	NULL
Monocyte-specific	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
prointerleukin	NULL
1	NULL
beta	NULL
gene	NULL
(	NULL
IL1B	NULL
)	NULL
is	NULL
dependent	NULL
upon	NULL
promoter	NULL
sequences	NULL
which	NULL
bind	NULL
the	NULL
hematopoietic	NULL
transcription	NULL
factor	NULL
Spi-1/PU.1	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:58	NULL
,	NULL
1995	NULL
45	NULL
.	NULL

Galson	NULL
DL	NULL
,	NULL
Housman	NULL
DE	NULL
:	NULL
Detection	NULL
of	NULL
two	NULL
tissue-specific	NULL
DNA-binding	NULL
proteins	NULL
with	NULL
affinity	NULL
for	NULL
sites	NULL
in	NULL
the	NULL
mouse	NULL
beta-globin	NULL
intervening	NULL
sequence	NULL
2	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:381	NULL
,	NULL
1988	NULL
46	NULL
.	NULL

Wasylyk	NULL
C	NULL
,	NULL
Kerckaert	NULL
JP	NULL
,	NULL
Wasylyk	NULL
B	NULL
:	NULL
A	NULL
novel	NULL
modulator	NULL
domain	NULL
of	NULL
Ets	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
6:965	NULL
,	NULL
1992	NULL
47	NULL
.	NULL

Lim	NULL
F	NULL
,	NULL
Kraut	NULL
N	NULL
,	NULL
Framptom	NULL
J	NULL
,	NULL
Graf	NULL
T	NULL
:	NULL
DNA	NULL
binding	NULL
by	NULL
c-Ets-1	NULL
,	NULL
but	NULL
not	NULL
v-Ets	NULL
,	NULL
is	NULL
repressed	NULL
by	NULL
an	NULL
intramolecular	NULL
mechanism	NULL
.	NULL

EMBO	NULL
J	NULL
11:643	NULL
,	NULL
1992	NULL
48	NULL
.	NULL

Law	NULL
SK	NULL
,	NULL
Gagnon	NULL
J	NULL
,	NULL
Hildreth	NULL
JE	NULL
,	NULL
Wells	NULL
CE	NULL
,	NULL
Willis	NULL
AC	NULL
,	NULL
Wong	NULL
AJ	NULL
:	NULL
The	NULL
primary	NULL
structure	NULL
of	NULL
the	NULL
beta-subunit	NULL
of	NULL
the	NULL
cell	NULL
surface	NULL
adhesion	NULL
glycoproteins	NULL
LFA-1	NULL
,	NULL
CR3	NULL
and	NULL
p150,95	NULL
and	NULL
its	NULL
relationship	NULL
to	NULL
the	NULL
fibronectin	NULL
receptor	NULL
.	NULL

EMBO	NULL
J	NULL
6:915	NULL
,	NULL
1987	NULL
49	NULL
.	NULL

Chen	NULL
HM	NULL
,	NULL
Pahl	NULL
HL	NULL
,	NULL
Scheibe	NULL
RJ	NULL
,	NULL
Zhang	NULL
DE	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
The	NULL
Spl	NULL
transcription	NULL
factor	NULL
binds	NULL
the	NULL
CD11b	NULL
promoter	NULL
specifically	NULL
in	NULL
myeloid	NULL
cells	NULL
in	NULL
vivo	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
myeloid-specific	NULL
promoter	NULL
activity	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:8230	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blood	NULL
==	NULL
Neutrophils	NULL
and	NULL
monocytes	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
PU.1	NULL
(	NULL
Spi-1	NULL
)	NULL
but	NULL
not	NULL
Spi-B	NULL
4	NULL
_	NULL
gs	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
0	NULL
;	NULL
2108	NULL
HM	NULL
Chen	NULL
,	NULL
P	NULL
Zhang	NULL
,	NULL
MT	NULL
Voso	NULL
,	NULL
S	NULL
Hohaus	NULL
,	NULL
DA	NULL
Gonzalez	NULL
,	NULL
CK	NULL
Glass	NULL
,	NULL
DE	NULL
Zhang	NULL
and	NULL
DG	NULL
Tenen	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/85/10/2918.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

